Curriculum Vita

Name: Fahimeh

Surname: Ramezani Tehrani

Nationality: Iranian

Date of birth: 05/05/1966

Place of Birth: Qazvin/Iran

Marital status: Married

Academic Educations

• Tehran University, School of Medicine                                        1984-1990

General Medicine

Tehran Iran

• Tehran University School of Medicine                                         1990-1994

Obstetrics &Gynecology

Tehran Iran

• Harvard School of Public Health                                                  2004-2005

Takemi Fellowship,

Boston, USA

Academic Position

Official Positions

Research Training Courses

• Workshop on Research Methodology –Iran 1997

• Workshop on Advanced Methodology for Reproductive Health Research   Iran 1997

• Workshop on Report Writing – Iran 1997

• Workshop on Focus Group Discussion (by Judi Abbot) Iran 1998

• Workshop on Qualitative Research (by Garsia Noonez) Iran 1998

• Workshop on Operational Research, Nepal, C.S.T Committee WHO 1998

• Workshop on Statistical Software (Stata) Iran 1998

• Workshop on Statistical Software (SPSS) Iran 1998

• Workshop on Statistical Software (Stata) Iran 1998

• Workshop on Clinical Trial Iran 1998

• Workshop on Focus Group Discussion (Advanced), Iran 1999

• Workshop on Strengthening Researcher Capability, Iran 2000

• Training course on Reproductive Health Research for Adolescence, Syria by WHOM, 2001

• Workshop on Data Analyzing and Interpretation (by Khan) Iran, 2001

• Workshop on Total Quality Management, Iran, 2002

• Workshop on Strategic Planning, Iran, 2002

• Training course on Counseling in HIV/AIDS Program Iran, 2003

• Training course on Health Communication in Sensitive Issues, Iran 2003

• Harm Reduction Workshop, Iran, 2004

• Workshop on Integration of HIV/AIDS in PHC, Iran, 2004

• Infertility training course, Boston IVF center, supervisor Dr. Selwyn P. Oskowitz, 2004-2005

Clinical training course

• Infertility training course, Boston IVF center, supervisor Dr. Selwyn P. Oskowitz, 2004-2005

• Urogynecological surgery course, Urogynecologic Departement, supervisor Dr. Peter Rosenbelt , 2005-2006

• Short training course on basic and advanced Laparoscopy & Hysterescopy, 2007,2008,2009,2010,2013,2015, 2018 each year one week.

• Short training course on basic and advanced colposcopy, 2018, 2020.

Membership in International Scientific Associations

1-American Society for Reproductive Medicine (ASRM)

https://www.asrm.org/

2- Society of Laparoendoscopic Surgeons (SLS)

https://www.laparoscopic.md/links/sls-society-laparoendoscopic-surgeons

3-European Society of Human Reproduction and Embryology (ESHRE)

https://www.eshre.eu/

4- Androgen Excess and PCOS Society (AE-PCOS)

http://www.ae-society.org/

National & international achievements and awards

1. The first rank of scientometrics according to the Iranian Scientometric Information Database (ISID ) among all obstetricians and gynecologists.

http://isid.research.ac.ir/Fahimeh_RamezaniTehrani

2. 1% of the world's top researchers in the field of reproductive endocrinology

https://scholar.google.com/citations?hl=en&user=R056NX8AAAAJ

https://www.researchgate.net/profile/Fahimeh_Ramezani_Tehrani

https://www.linkedin.com/in/fahimeh-ramezani-tehrani-md-22450a37/?originalSubdomain=ir

3. Top 2% Scientist Stanford report, 2021

4. Top Researcher Award at 9^th Abu Reihan Biruni Research Festival of Shahid Beheshti University of Medical Sciences, 2010

5. Selected Article Award at 26^th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE),2010, in Italy

6. The fifth rank of clinical surgeons of the 18^th Razi Research Festival of Medical Sciences

7. Selected Article Award at 21^st  annual meeting of the Society of Laparoendoscopic Surgeons (SLS)

8. Award of the 19^th Razi Research Festival of Medical Sciences

9. Top Researcher Award at 11^th Abu Reihan Biruni Research Festival of Shahid Beheshti University of Medical Sciences, 2012

10. Selected Article Award at 12^th Abu Reihan Biruni Research Festival of Shahid Beheshti University of Medical Sciences, 2013

11. Award of the top researcher in the field of women's health research in 2014

12. Top Researcher Award at 16^th Abu Reihan Biruni Research Festival of Shahid Beheshti University of Medical Sciences, 2017

13. Selected Article Award of the International Federation of Gynecology and Obstetrics (FIGO),2018

14. Selected Article Award of the 17th annual meeting of androgen excess & PCOS Society,2019

International patent

1. Prediction of age of menopause using AMH serum concentration, 2010
2. Ointment Containing Hops Nanoparticl for the Treatment of Menopausal Symptoms”

https://patents.google.com/patent/US20180028436A1/en

Presentation in International Conferences/ congresses/ seminars/ meetings

1. 14th international AIDS conference, Spain, 7-12 July 2002, Oral presentation; Promotion of sexual reproductive health among youth of Islamshar.
2. 25th congress medical women's international association, Australia, 20-24 April 2002, Oral presentation; Unwanted Pregnancy in Tehran, What are the risk factors?
3. 18th world conference on Health Promotion and Health Education, Australia, 26-30 April 2004, Oral presentation; Smoking habits of general practitioners in Iran.
4. The 4th Congress of the European Society of Contraception & Reproductive Health Care, UK, 10-15 June 2004, Oral presentation; Peer group education in sexual reproductive health among university students.
5. 3rd   Asia Pacific Conference on Reproductive and Sexual Health, Malaysia, 17-27 November 2005, Oral presentation; Knowledge, attitude and practice regarding HIV/AIDS among Iranian at risk population.
6. Reproductive Disruptions (Childlessness, Adoption and other Reproductive Complexities), USA, 19-22 May 2005, Oral presentation; Gender disparity in reproductive health needs of youth.
7. International Seminar on Sexual and Reproductive Transitions of Adolescents in Developing Countries, Mexico, 6-9 November 2006, Oral presentation; Reproductive Knowledge, Attitudes and Behavior Among Adolescent Males in Tehran, Iran, and risk taking sexual behaviors among adolescent boys aged 15-18 in Tehran.
8. 15th International congress & ENDO EXPO SLS annual meeting, USA, 6-9 September 2006, Oral presentation; Laparoscopic treatment of polycystic ovaries with needle cautery.
9. 13th world congress of gynecological endocrinology, Italy, 2007, Oral presentation; What are the risk factors of premature ovarian failure and early menopause among under coverage of Tehran East Health Center?
10. 13th world congress of gynecological endocrinology, Italy, 2007, Poster presentation, Menarcheal age of mothers and daughters: Tehran Lipid and Glucose.
11. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Oral presentation; Does considering polycystic ovary syndrome according to the Rotterdam consensus change its association with metabolic factors.
12. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Oral presentation; Is ovarian ageing is delayed in women with PCOS?
13. 1st Arab and Iranian Congress of Endocrinology and diabetes, Syria, 9-11 April 2008, Invited speaker; Prenatal complication of PCOS.
14. 8th International Congress of  Endocrine Disorders & 2nd Arab-Iran congress of Endocrinology & Metabolism, Tehran, 27-28 October 2009, Chairman; Controversies in the definition of PCOS.
15. UNFPA Report, UNFPA, 24 May2009, Invited speaker; Study on Reproductive Morbidities of women.
16. 65th Annual meeting ASRM 2009, USA, 17-21 October, 2009, Poster presentation, Is polycystic ovary syndrome an exception for reproductive aging?
17. 9th Asia and Oceania Thyroid Association Congress, Japan, November 2009, Poster presentation. Is thyroid function associated with components of the metabolic syndrome in euthyroid subjects of reproductive age?
18. 26th annual meeting ESHRE , Italy, 27-30 June 2010, Oral presentation; Whether age at menopause is predictable using AMH serum concentration?
19. 20th SLS anniversary meeting and endo expo, California, 14-17 September, 2011, Oral presentation; Reproductive Outcome After Laparoscopic Treatment of Mild Endometriosis in Unexplained Infertility.
20. 21st SLS annual meeting, Boston, 5-8 September, 2012, Oral presentation; Whether ovarian reserve is reduced in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
21. 5th international congress IRHRC on reproductive health and family helath "Menopause and Andropause", Tehran 26-28 Dec 2012, Oral Presentation; effect of menopausal Iranian women sexual attitude on their sexual activity.
22. 5th international congress IRHRC on reproductive health and family helath "Menopause and Andropause", Tehran 26-28 Dec 2012, Oral Presentation; perceived concern in menopausal women.
23. The Comparison of the Effect of Two Different Doses of Testosterone on Development of Polycystic Ovary Syndrome-Like Phenotype in Female Rat's Offspring in Adulthood? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
24. The Association Between Insulin Resistance and Diabetogenic Polymorphisms is Highly Influenced by PCOS Status ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
25. Psychometric Properties of Questionnaire of Quality of Life for Polycystic Ovary Syndrome (PCOSQ-43): Fitness Model Through Factor Analysis ? 10th  International Congress of Endocrine Disorders
26. Socio-Behavioral and Reproductive Predictors of  Onset of Menopause in Women with and without Metabolic Syndrome: Tehran Lipid and Glucose Study ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
27. Prevalence of Secondary Infertility among 18-45 Year Old Iranian Women ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
28. Lipid Profile in Obese and Non-Obese Women with Polycystic Ovary Syndrome: A Community Based Study in Southwest of Iran ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
29. Not Using Universal Thyroid Screening Test During Early Pregnancy Will Overlook Three of Every Four Women with Thyroid Disorders ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
30. Comparing the Association Between Birth Weight and Body Fat Mass in Reproductive Women with Poly Cystic Ovary Syndrome and their Age-BMI Matched Eumenorrheic Non-Hirsute Controls ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
31. Do Women with Polycystic Ovaries Reach Menopause Later? ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014

32. The Association Between Duration of Oral Contraceptive Pills Consumption with Risk Factors of Cardiovascular Disease in Non Menopausal Women: Tehran Lipid and Glucose Study. 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
33. Development and Psychometric Properties of the Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire ? 10th  International Congress of Endocrine Disorders; 22-24 Oct 2014
34. Health-Related Quality of Life in Hirsute Women Suffering from Polycystic Ovary Syndrome . 10th  International Congress of Endocrine Disorders? 22 Oct 2014 ?????  24 Oct 2014
35. Dimensions and Components of Quality of Life in Women with Polycystic Ovary Syndrome: A Qualitative Study from Iran ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
36. Is Menopause Event a Cardio-Metabolic Risk Factor in Middle-Aged Women? A Population-Base Longitudinal Study ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
37. Do Women with Polycystic Ovaries Reach Menopause Later? ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
38. Do Women with Polycystic Ovaries Reach Menopause Later? ? 10th  International Congress of Endocrine Disorders; 22 -24 Oct 2014
39. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. Oral presentation; reproductive Endocrinology. Tehran: Razi Conference Hall.
40. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. Poster presentation; "Is there association between menopause and serum level of nitric oxide?" Tehran: Razi Conference Hall.
41. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. Poster presentation; "comparison of the effects of androgen on sexual function in women with and without polycystic ovary syndrome (PCOS)" Tehran: Razi Conference Hall.
42. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; "Prevalence of pregnancy complications in differenr phenotypes of polycystic ovary syndrome" Tehran: Razi Conference Hall
43. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. poster presentation; "Subclinical hypothyroidism in pregnancy and miscarriages" Tehran: Razi Conference Hall
44. The 2th International congress on reproduction (ISERB 2016), 18-20 may 2016. Poster presentation; "Thyroid disorder symptoms and sign during pregnancy" Tehran: Razi Conference Hall.
45. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation, Risk of metabolic syndrome in polycystic ovary syndrome: Tehran Lipid and Glucose Study. Tehran: Shahid Beheshti International Convention Center.
46. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation, Gestational diabetes mellitus (GDM); current evidence and controversies. Tehran: Shahid Beheshti International Convention Center.
47. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Is Serum Androgen Level Predictive of Female Sexual Function in Women with Polycystic Ovary Syndrome? Tehran: Shahid Beheshti International Convention Center.
48. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Effects of Levothyroxine Treatment on Pregnancy Outcomes in Subclinical Hypothyroidism Pregnant Women. Tehran: Shahid Beheshti International Convention Center.
49. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. The knowledge of Iranian general practitioners regarding diagnosis and treatment of polycystic ovary syndrome. Tehran: Shahid Beheshti International Convention Center.
50. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Risk of pre-hypertension and hypertension in polysystic ovary syndrom: Tehran Lipid and Glucose Study. Tehran: Shahid Beheshti International Convention Center.
51. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. Oral presentation. Correlations between Female Sexual Function Index and hormonal levels in women with polycystic ovary syndrome and healthy women. Tehran: Shahid Beheshti International Convention Center.
52. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Refining the psychometric properties of health related quality of life among women with polycystic ovary syndrome (PCOSQ-50). Tehran: Shahid Beheshti International Convention Center.
53. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Does unilateral oophorectomy increase the adverse cardio-metabolic effects attributed to surgical menopause? A community based cohort study. Tehran: Shahid Beheshti International Convention Center.
54. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Does unilateral oophorectomy increase the adverse cardio-metabolic effects attributed to surgical menopause? A community based cohort study. Tehran: Shahid Beheshti International Convention Center.
55. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Assessment the insulin resistance by Homa-IR in obesity and polycystic ovary syndrome: systematicreview and meta-analysis of observational studies. Tehran: Shahid Beheshti International Convention Center.
56. The 11th international Congress of Endocrine Disorders, 2-4 Nov 2016. poster presentation. Evaluation the insulin sensitivity by Insulin Sensitivity Index (ISI) in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Tehran: Shahid Beheshti International Convention Center.
57. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Oral presentation. Cardiometabolic consequences of polycystic ovary syndrome; a population based cohort study with 15 years of follow up. Beijing, China.
58. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Oral presentation. Levothyroxine Treatment in pregnant women with autoimmune thyroid disease: prenatal and neonatal outcomes. Beijing, China.
59. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Age-specific Anti-Müllerian Hormone and Ischemic Changes of Electrocardiography. Beijing, China.
60. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Whether billewicz scoring method precisely predicts thyroid dysfunction in pregnant women? A population based cohort study.. Beijing, China.
61. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Whether billewicz scoring method precisely predicts thyroid dysfunction in pregnant women? A population based cohort study.. Beijing, China.
62. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Menstrual cycle irregularity and metabolic disorders, a population based prospective study. Beijing, China.
63. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. The Relationship between Serum Total Testosterone and Sexual Function among Post-menopausal Women. Beijing, China.
64. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Prenatal exposure to androgen excess affects sexual function of women with polycystic ovary syndrome in adulthood. Beijing, China.
65. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Association between idiopathic hirsutism and metabolic syndrome (Tehran Lipid and Glucose Study). Beijing, China.
66. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. Co-Culture of Human Peripheral Blood Lymphocytes from Patients with Polycystic Ovary Syndrome (PCOS) with Ovarian Tumor Cell Lines (SKOV3, A2780): Study of Their In-Vitro Immunological Interactions and Comparison to Healthy Women. Beijing, China.
67. 17th International Congress of Endocrinology, ICE-CSE Aug 31 - Sept 4th 2016.  Poster presentation. The study of TNF-? cytokine production, expression of CD8 marker and proliferation of peripheral blood lymphocyte of multiparous women compared with nulliparous women by Co-culture with MDA-231 and MCF-7 breast tumor cell lines. Beijing, China.
68. 14th Annual AE-PCOS Meeting, 10-12 Nov 2016. Oral Presentation. cardio-metabolic events among women with polycystic ovary syndrome: a long term populationbased prospective cohort study Australia.
69. 16th Annual AE-PCOS Meeting, 10-12 Nov 2018. Oral Presentation.Stockholm, Sweden? September 23-25, 2018
70. 17th Annual AE-PCOS Meeting, 7-9 Nov 2016. Oral Presentation. Age specific anti-Mullerian hormone (AMH) can precisely predict polycystic ovary syndrome (PCOS). Foz do Iguaçu, Brazil.
71. 21st Royan International Congress on Reproductive Biomedicine, 2-4 Sep 2020.  Oral Presentation. Obesity and Sexual Dysfunction in Men and Women. Iran.
72. 9^th Yazd International Congress & student award on reproductive medicine, 13-15 May 2021. Oral presentation. Anti-Mullerian hormone and polycystic ovary syndrome.

Publications

Writing book chapter in English

1. Fertility forecasting: advances in the role of anti-mullerian hormone as a reproductive biomarker
2. Contemporary Gynecologic Practice- chapter: Polycystic Ovary Syndrome(PCOS)
3. Vitamin D- Chapter: Vitamin D and Human Reproduction
4. Cardio-metabolic Diseases and Risk Factors. Chapter: Cardio-metabolic risk factors in polycystic ovary syndrome

Writing book /chapter in Persian

1. Reproductive morbidities among Iranian women, 2009
2. Endocrine disorders, chapter:reproduction
3. Epidemiology and control of common disorder in Iran, chapter: polycystic ovary syndrome
4. Fasting and health, chpter: Fasting in pregnancy

Published Articles

1. Barooti E, Ramezani Tehrani F, Hydari M, Mohammad K. Prevalence of primary infertility based on marriage age, Hakim Journal 1999; 2(2): 88-93.

https://www.sid.ir/fa/journal/ViewPaper.aspx?ID=35520

2. Jahanfar S, Ramazai Tehrani F, Sadat Hashemi M. Unwanted Pregnancy and Abortion. Iranian Journal of Nursing and Midwifery summer 2000; 13(25): 23-27.

http://ijn.iums.ac.ir/browse.php?a_code=A-10-1-160&slc_lang=fa&sid=fa

3. Ramezani Tehrani F, Hejazi S, Aflaki S. effective factors on correct contraceptive use. The Journal of Qazvin University of Medical Science Summer 2000; 4(14): 37-43.

https://www.sid.ir/fa/Journal/ViewPaper.aspx?ID=44149

4. Jahanfar Sh, Sadat Hashemi SM, Ramezani Tehrani F. The assessment of in fluency factors on unwanted pregnancy using logic regration analysis; a study among women refer to clinic Tehran medical university. Daneshvar  2000, 8(29): 21-26.

https://www.sid.ir/Fa/Journal/ViewPaper.aspx?ID=25433

5. Ramezani Tehrani F, Kazem M, Rahgozar M, Naghavi M. Knowledge and practice of Iranian women toward cervical cancer. Medical Journal of Reproduction & Infertility 2001; 2(5): 50-56

https://www.sid.ir/en/journal/ViewPaper.aspx?id=46384

6. Rahgozar M, Kazem M,  Ramezani Tehrani F. Trend of still birth rate in Iranian women aged 15-49 years during four decade from 1957-1996, Hakim Research Journal Summer 2001; 4(2): 85-91.

https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=31007

7. Ramezani Tehrani  F, Khaladj Abadi Farahani F, Sadat Hashemi M. Factors influencing contraceptive use in Tehran. Family Practice 2001; 18(2): 204-208.

https://pubmed.ncbi.nlm.nih.gov/11264273/

8. Ramezani Tehrani F, Sadat Hashemi SM, Heidari Seraj M. Comparison of tubal ligation by bipolar electroagulation and filshie-clips. The journal of Qazvin University of Medical Science Winter 2002; 20: 35-41.

https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=47706

9. Seyf Rabiei MA, Ramezani Tehrani F, Hatmi Z. Wife Abuse and Related Factors. Women in Development & Politics 2002; 4(1): 25-52.

https://www.sid.ir/fa/journal/ViewPaper.aspx?ID=26199

10. Ramezani Tehrani F, Pakniyat H, Naji A, Asefzadeh S. Thyroid hormone Variations in pre-eclampsia. The Journal of Qazvin University of Medical Science 2002; 24: 18-23.

http://journal.qums.ac.ir/article-1-416-fa.html

11. Jahanfar S, Ramezani Tehtani F, Hashemi M. Early complication of menopause among women in Tehran. Reproduction & Infertility 2002; 3(10): 31-40.

http://www.jri.ir/article/83

12. Jahanfar Sh, Ramezani Tehrani F, Hashemi M. The prevalence of unwanted pregnancies and its effective factors  in 10 cities, The Journal of Faculty of Medicine. Tehran University of Medical Science 2002; 60(4): 334-340.

https://tumj.tums.ac.ir/article-1-1247-fa.html

13. Ramezani Tehrani F, Aghaee M, Asefzadeh S. The comparison of thyroid function tests in cord blood following cesarean section or vaginal delivery. International  Journal of Endocrinology and Metabolism 2003; 1(1): 22-26.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=34530

14. Simbar M, Ramezani Tehrani F, Hashemi Z. The needs of reproductive health of the university students of Qazvin. The Journal of Qazvin Univ. of Med.Sci Autumn Supplement 2003; 28: 5- 13.

http://journal.qums.ac.ir/browse.php?a_id=203&sid=1&slc_lang=en

15. Mohammadi MR, Mohammad K, Khalajabadi Farahani F, Alikhani S, Zare M, Ramezani Tehrani F, A. et al. Reproductive knowledge, attitude and practice of Tehranian adolescent boys ahed 15-18 years, 2002. Reproduction & Infertility Summer 2003; 4(3): 237-250.

https://www.sid.ir/en/journal/ViewPaper.aspx?ID=2638

16. Simbar M, Ramezani Tehrani F, Hashemi Z. Knowledge, attitude and practice of reproductive health of university students. Pajohande 2003; 8(4): 9-15.

https://www.sid.ir/fa/journal/ViewPaper.aspx?ID=1650

17. Simbar M, Ramezani Tehrani F, Hashemi Z. Sexual-Reproductive Health Belief Model of college students. South Teb Aug 2004; 7(1): 70-78.

http://ismj.bpums.ac.ir/article-1-86-en.html

18. Simbar M, Ramezani Tehrani F, Hashemi Z. Reproductive health knowledge, attitudes and practices of Iranian college students. Eastern Mediterranean Health Journal 2005;  11(5-6): 888-897.

https://pubmed.ncbi.nlm.nih.gov/16761658/

19. Mohammadi MR, Mohammad K, Khalaj Abadi Farahani F, Alikhani S, Zare M, Ramezani Tehrani F, et al. Reproductive Knowledge, Attitudes and Behavior Among Adolescent Males in Tehran, Iran. International Family Planning Perspectives 2006; 32(4): 35-44.

https://pubmed.ncbi.nlm.nih.gov/16723300/

20. Ramezani Tehrani F, Malekafzali H, Jalalinia Sh, Rostami dovvom M, Peikari N. General practitioners knowledge about smoking cessation approaches. Medical Science Journal of Islamic Azad University 2006; 16(3): 155-159.

http://tmuj.iautmu.ac.ir/browse.php?a_code=A-10-1-117&slc_lang=en&sid=1&sw=Cigarette+smoking

21. Simbar M, Ramezani Tehrani F, Hashemi Z, Zham H, Fraser IS. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. J Fam Plann Reprod Health Care 2007; 33(4): 271-276.

https://pubmed.ncbi.nlm.nih.gov/17925114/

22. Ramezani Tehrani F, Malekafzali H, Djalalinia Sh, Rostami Dovom M, Peikari N. Training of general practitioners about smoking cessation counseling. Hakim Summer 2007; 10(2): 15-20.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=101053

23. Mohammad K, Khalaj Abadi Farahani F, Mohammadi MR, Alikhani S, Zare M, Ramezani Tehrani F, et al. Sexual Risk-Taking Behaviors among Boys Aged 15–18 Years in Tehran, 20. Journal of Adolescent Health  2007 oct; 41(4): 407-414.

https://pubmed.ncbi.nlm.nih.gov/17875467/

24. Ramezani Tehrani F, Malekafzali H. Knowledge, attitudes and practices concerning HIV/AIDS among Iranian at-risk sub-populations. Eastern Mediterranean Health journal 2008; 14(1): 142-156.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Knowledge%2C+attitudes+and+practices+concerning+HIV%2FAIDS+among+Iranian+at-risk+sub-populations

25. Paikari N, Ramezani Tehrani F, Malek-Afzali H, Jalalinia Sh. Assessment of key stockholders regarding the practice of counseling centers for university students. Journal of medical council of Islamic republic of Iran 2008, 25(4): 431-439.

26. Ramezani Tehrani F, Moini A, Khalaj F, Skandarloo M. Laparoscopic treatment of polycystic ovaries with needle cautery in Clomiphen resistant patients. Journal of Zanjan University of medical sciences 2008; 16(62): 59-67.

https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=126039

27. Ramezani Tehrani F, Solaymani-Dodaran M, Aziz F. A single test of antimu¨llerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause: The Journal of The North American Menopause Society 2009; 16(4): 797-802.
28. Farahmand M, Ramezani Tehrani F, Azizi F. The Influence of Serum Lipoprotiens and Body Mass Index on the Age of Menarche. Iranian Journal of Endocrinology and Metabolism 2009; 11(4): 415-421.

http://ijem.sbmu.ac.ir/article-1-857-en.html

29. Simbar M, Nahidi F, Ramezani Tehrani F, Ramezankhani A. Father’s educational needs for perinatal care in urban Iran: A qualitative approach, J. Biosoc. Sci 2010, Vol. 42, pp. 633-641.

https://pubmed.ncbi.nlm.nih.gov/20470446/

30. Ramezani Tehrani F, Mirmiran P, Zahedi-Asl S, Nakhoda K, Azizi F. Menarchel age of mothers and daughters: Tehran Lipid and Glucose study. Eastern Mediterranean Health Journal 2010; 16(4): 391-395.

https://pubmed.ncbi.nlm.nih.gov/20795422/

31. Ramezani Tehrani F, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Human Reproduction 2010; 25(7): 1775-1781.
32. Peykari N, Ramezani Tehrani F, Malekafzali H, Rostami Dovvom M, Djalalinia Sh. Smoking Habits among Iranian General Practitioners. J Egypt Public Health Assoc 2010; 85(1): 96-112.

https://www.ncbi.nlm.nih.gov/pubmed/21073850

33. Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum Anti -Mullerian Hormone serum concentration. Menopause: The Journal of The North American Menopause Society 2011; 18(7): 766-770.

https://www.ncbi.nlm.nih.gov/pubmed/2145142

34. Peykari N, Ramezani Tehrani F, Malek-afzali H, Hashemi Z, Djalalinia Sh. An experience of Peer Education Model among Medical Science University Students in Iran. Iranian J Publ Health 2011; 40(1):  57-62.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481725/

35. Ramezani Tehrani F, Simbar M, Abedini M. Reproductive morbidity among Iranian women; issues often inappropriately addressed in health seeking behaviors. BMC Public Health 2011 Nov 14; 11: 863.

https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-11-863

36. Peykari N, Ramezani Tehrani F, Baradaran Eftekhari M, Malekafzali H, Dejman M. Rosemary Neot, Shirin Djalalinia, A peer-based study on adolescence nutritional health: A lesson learned from Iran. J Pak Med Assoc 2011; 61(6): 549-554.

https://www.ncbi.nlm.nih.gov/pubmed/22204208

37. Ramezani Tehrani F, Hashemi S, Simbar M, Shiva N. Screening of the pelvic organ prolapse without a physical examination; (a community based study). BMC Women’s Health 2011 nov; 15; 11: 48.

https://www.ncbi.nlm.nih.gov/pubmed/22082121

38. Simbar M, Nahidi F, Ramezani-Tehrani F, Akbarzadeh A. Educational needs assessment for men’s participation in perinatal care. Eastern Mediterranean Health Journal 2011; 17( 9): 689-696.

https://www.ncbi.nlm.nih.gov/pubmed/22259920

39. Ramezani Tehrani F. LETTERS TO THE EDITOR. Menopause: The Journal of The North American Menopause Society 2011; 18(12): 1334-1335.

https://journals.lww.com/menopausejournal/Fulltext/2011/12000/In_response.15aspx

40. Peykari N, Ramezani Tehrani F, Malek Afzali H, Baradaran Eftekhari M, Djalalinia Sh. The key stakeholders' opinions regarding university counseling centers: An experience from Iran. J Res Med Sci 2011; 16(9): 1202-9.

https://pubmed.ncbi.nlm.nih.gov/22973390/

41. Ramezani Tehrani F, Rashidi H,  Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reproductive Biology and Endocrinology 2011 Nov 1;  9: 144.

https://pubmed.ncbi.nlm.nih.gov/22044512/

42. Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimu¨llerian hormone concentration. Menopause: The Journal of The North American Menopause Society 2011; 18(7): 766-770.

https://pubmed.ncbi.nlm.nih.gov/21451424/

43. Ramezani Tehrani F, Simbar M, Tohidi M,  Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology 2011 Mar 25;  9: 39.

https://pubmed.ncbi.nlm.nih.gov/21435276/

44. Hosseinpanah F, Barzin M, Ramezani Tehrani F, Azizi F. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS Prevalence Study. Clinical Endocrinology 2011; 75(5): 962-697.

https://pubmed.ncbi.nlm.nih.gov/21592169/

45. Ramezani Tehrani F, Tohidi M, Rostami Dovom M, Azizi F. A Population Based Study on the Association of Thyroid Status with Components of the Metabolic Syndrome. Diabetes & Metabolism 2011; 2(8): 1-5.

https://www.longdom.org/abstract/a-population-based-study-on-the-association-of-thyroid-status-with-components-of-the-metabolic-syndrome-26155.html

46. Ramezani Tehrani F, Hashemi S, Hasheminia M, Azizi F. Metabolic Disorders in Women with Previous Gestational Diabetes Mellitus, Tehran Lipid and Glucose Study. Iranian Journal of Endocrinology and Metabolism Novamber 2011; 13(4):  339-345.

http://ijem.sbmu.ac.ir/article-1-1137-en.html

47. Ramezani Tehrani F, Simbar M, Abedini M. Prevalence of Reproductive Morbidity in Four Selected Provinces in Iran. Hakim Research Journal 2011; 14(1): 32- 40.

http://hakim.hbi.ir/browse.php?a_id=778&sid=1&slc_lang=en

48. Farahmand M, Ramezani Tehrani F, Azizi F. Menopause age and affecting factors in Tehran Lipid and Glucose Study (TLGS). The Journal of Qazvin University of Medical Sciences 2011; 15(1): 48-55.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=194556

49. Ramezani Tehrani F, Amiri P, Simbar M, Rostami Dovom M, Azizi F. Do Men Consider Health as a Priority? A Qualitative Study. Hakim Research Journal  2011; 13(4): 241-249.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=244390

50. Ramezani Tehrani, F, Tohidi, M, Rostami, M, Asgari, S, Azizi, F. The association between sub-clinical hypothyroidism and metabolic syndrome: A population based study. Iranian Journal of Endocrinology and Metabolism.Volume 13, Issue 1, 2011, Page 123

https://www.sid.ir/en/journal/ViewPaper.aspx?id=200359

51. Jalalinia Sh, Ramezani Tehrani F, Baradaran Eftekhari M, Peykari N. Qualitative study of adolescences opinion among nutritional habits and believes. Medical Sciences Journal of Islamic Azad University Winter 2011; 20(4): 258-264.

https://pubmed.ncbi.nlm.nih.gov/21831271/

52. Ramezani Tehrani F, Farahmand M, Amiri P, Paikari N, Azizi F. Women’s Perception Regarding to Healthy Nutrition Inhibitors: a Qualitative Research in Tehran Lipid and Glucose Study (TLGS). Iranian Journal of Endocrinology and Metabolism May 2011; 13(1): 48-57.

https://www.semanticscholar.org/paper/Women%E2%80%99s-Perception-Regarding-to-Healthy-Nutrition-a-Tehrani-Farahmand/966bd17c827707231c99ae5dfe231ca278f26b27

53.  Zadeh-Vakili A, Ramezani Tehrani F, Hosseinpanah F. Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetology & Metabolic Syndrome 2011, 3(18): 1-6.

https://pubmed.ncbi.nlm.nih.gov/21831271/

54. Djalalinia Sh, Ramezani Tehrani F, Malekafzali H, Rostami Dovvom M. Training of general practitioners about smoking cessation counseling. J Pak Med Assoc 2011; 61(5): 449-452.

https://pubmed.ncbi.nlm.nih.gov/22204177/

55. Ramezani Tehrani F, Hashemi S, Hasheminia M, Azizi F. Follow-up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): A population-based cohort study. J. Obstet. Gynaecol. Res 2012; 38(4), 698–704.

https://pubmed.ncbi.nlm.nih.gov/22380591/

56. Djalalinia Sh, Ramezani Tehrani F, Malek Afzali H, Peykari N, Baradaran Eftekhari M. Community Mobilization for Youth Health Promotion: A Lesson Learned From Iran. Iranian J Publ Health 2012; 41(4): 55-62.

http://ijph.tums.ac.ir/index.php/ijph/article/view/2590

57. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Barriers to condom use among women at risk of HIV/AIDS: a qualitative study from Iran. BMC Women's Health 2012 may, 24; 12: 13.

https://bmcwomenshealth.biomedcentral.com/articles/10.1186/1472-6874-12-13

58. Zadeh-Vakili A, Ramezani Tehrani F, Hashemi S, Amouzegar A, Azizi F. Relationship between Sex Hormone Binding Globulin, Thyroid Stimulating Hormone, Prolactin and Serum Androgens with Metabolic Syndrome Parameters in Iranian Women of Reproductive Age. Diabetes & Metabolism 2012; S2-008: 1-8.

https://www.longdom.org/abstract/relationship-between-sex-hormone-binding-globulin-thyroid-stimulating-hormone-prolactin-and-serum-androgens-with-metabol-26313.html

59. Farahmand M, Ramezani Tehrani F, Azizi F. Whether age of menarche is influenced by body mass index and lipoproteins profile? A retrospective study. Iran J Reprod Med July 2012; 10(4):  373-378.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165951/

60. Hashemi S, Simbar M, Ramezani-Tehrani F,  Shams J, Alavi Majd H. Anxiety and success of in vitro fertilization. European Journal of Obstetrics & Gynecology and Reproductive Biology Sep 2012; 164(1): 60-64.

https://pubmed.ncbi.nlm.nih.gov/22727918/

61. Ramezani Tehrani F. A long way is ahead of prediction of menopause! Int J Endocrinol Meta 2012, 10(3): 521-522.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693631/

62. Ramezani Tehrani F, Farahmand M, Abedini M, Hashemi Z. Prevalence of vaginitis in Iranian women-- symptoms and clinical association. Medical Science Journal of Islamic Azad University  2012; 22(1): 62-68.

http://tmuj.iautmu.ac.ir/browse.php?a_id=544&sid=1&slc_lang=en

63. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Socioenvironmental barriers of using condom among women at risk of HIV/AIDS. payesh September- October 2012; 11(5):  669-678.

http://payeshjournal.ir/article-1-425-en.pdf

64. Ramezani Tehrani F, Farahmand M, Amiri P, Ghanbarian A, Azizi F. Healthy nutrition inhibitors from the perception of Tehranian men: A qualitative study. payesh September- October 2012; 11(5): 725-735.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=277659

65. Haghighi S, Yaghmaei P, Hashemi F, Saadati N, Ramezani Tehrani F, Hedayati M. The association between serum chemerin concentration and polycystic ovarian syndrome. Tehran University Medical Journal August 2012; 70(5), 320-324.

https://tumj.tums.ac.ir/browse.php?a_id=117&sid=1&slc_lang=en

66. Farahmand M, Ramezani Tehrani F, Mehrabi Y, Azizi F. Occurrence of Metabolic Syndrome and Components in Postmenopausal Women with Natural or Surgical Menopause. Iranian Journal of Endocrinology and Metabolism July 2012; 14(2): 117-126.

http://ijem.sbmu.ac.ir/browse.php?a_id=1311&sid=1&slc_lang=en

67. Hashemi F, Yaghmaei P, Saadati N, Haghighi Poodeh S, Ramezani Tehrani F, Hedayati M. Association of serum adipsin levels with polycystic ovarian Syndrome. Razi Journal of Medical Sciences Aug-Sep 2012; 19(99): 1-6.

http://rjms.iums.ac.ir/browse.php?a_id=2196&sid=1&slc_lang=en

68. Hashemi S, Ramezani Tehrani F, Hasheminia M, Azizi F, Evaluation the Risk of Metabolic Disorder in Women with Previous Preeclampsia Participated in Tehran Lipid and Glucose Study. Iranian Journal of Endocrinology and Metabolism March 2012; 13(6): 643-650.

http://ijem.sbmu.ac.ir/browse.php?a_id=1148&sid=1&slc_lang=en

69. Simbar M, Nahidi F, Ramezani Tehrani F, Ramezankhani A, Akbar Zadeh AR. Educational needs assessment for fathers' participation in perinatal care. Payesh, January - February 2012;  11(1): 39-49.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=218321

70. Saadati N, Yaghmaei P, Haghighi S, Hashemi F, Ramezani Tehrani F, Hedayati M. Association of Serum Omentin Levels in Women with PolyCystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism, November 2012; 14(4): 375-379.

http://ijem.sbmu.ac.ir/article-1-1374-en.html

71. Ramezani Tehra F, Hashemi S, Robab Allameh M. Prevalence of premenstrual syndrome and some of its relative factors in reproductive age. Ofogh-e-Danesh Journal, 2012; 18 (3): 121-127.

http://hms.gmu.ac.ir/browse.php?a_id=1129&slc_lang=en&sid=1&printcase=1&hbnr=1&hmb=1

72. Emadi M, Ramezani Tehrani F, Yaghmaei P, Sheikholeslami S, Hedayati M. Serum adiponectin levels and its association with insulin resistance and obesity in women with poly cystic ovarian syndrome. RJMS, 2012; 19 (101): 1-7.

http://rjms.iums.ac.ir/browse.php?a_id=2257&sid=1&slc_lang=en

73. Ramezani Tehrani F, Farahmand M, Mehrabi Y, Malek Afzali H, Abedini M. Prevalence of female sexual dysfunction and its correlated factors: a population based study(Views: 5). Payesh, November -December 2012; 11(6): 869-875.

https://www.sid.ir/en/journal/ViewPaper.aspx?ID=277792

74. Lotfi R, Ramezani Tehrani F, Merghati Khoei E, Yaghmaei F, Dworkin Sh L. How Do Women at Risk of HIV/AIDS in Iran Perceive Gender Norms and Gendered Power Relations in the Context of Safe Sex Negotiations? Arch Sex Behav, 2013 jul; 42(5): 873-881.

https://pubmed.ncbi.nlm.nih.gov/23224750/

75. Farahmanf F, Ramezani Tehrani F, Amiri P, Azizi F. Barries to healthy nutrition: perceptions and experiences of Iranian women. BMC Public Health, 2012 Dec 10;12: 1064.

https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-1064

76. Farahmand M, Ramezani Tehrani F, Pourrajabi L, Najafi M, Azizi F. Factors associated with menopausal age in Iranian women: Tehran Lipid and Glucose Study. The journal of obstetrics and gynaecology research, 2013 Apr; 39(4): 836-841.

https://pubmed.ncbi.nlm.nih.gov/23279558/

77. Djalalinia SH, Ramezani Tehrani F, Malek Afzali H, Hejazi F, Peykari N. Parents or School Health Trainers, which of them is Appropriate for Menstrual Health Education? Int J Prev Med, Sep 2012; 3(9): 622-627.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445278/

78. Ramezani Tehrani, F, Zadeh Vakili, A, Hashemi, S, Amuzegar, A, Azizi, F. Associations between hormonal profiles of urban Iranian women of reproductive age: A community based study of four provinces  Iranian Journal of Endocrinology and MetabolismVolume 14, Issue 1, 2012, 32-38.

http://ijem.sbmu.ac.ir/browse.php?a_id=1243&sid=1&slc_lang=en

79. Zadeh-Vakili A, Ramezani Tehrani F, Daneshpour M, Zarkesh M, Saadat N, Azizi F. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene, 2013 Feb 15; 515(1): 193-196.

https://pubmed.ncbi.nlm.nih.gov/23246977/

80. Hashemi S, Seddigh S, Ramezani Tehrani F, Hasanzadeh Khansari SM, Khodakarami N. Sexual ehavior of Married Iranian Women, Attending Taleghani Public Health Center. J Reprod Infertil. 2013;14(1): 34-38.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719361/

81. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone. J Clin Endocrinol Metab. 2013 Feb; 98(2): 729-735.

https://pubmed.ncbi.nlm.nih.gov/23316087/

82.  Nasiri Amiri F., Ramezani Tehrani F., Simbar M., Mohammadpour Tahmtan R. Concerns Of Women With Polycystic Ovary Syndrome: A Qualitative Study Iranian Journal Of Endocrinology And Metabolism (Ijem)   May 2013 , Volume 15 , Number 1 (Sn 67);  41 To 51.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=339147

83. Ramezani FR, Moslehi N,  Asghari G, Gholami R, Mirmiran P, Azizi F. Intake of Dairy Products, Calcium, Magnesium, and Phosphorus in Childhood and Age at Menarche in theTehran Lipid and Glucose Study. PLOS. 2013 Feb; 8(2): e57696.

https://pubmed.ncbi.nlm.nih.gov/23451261/

84. Hashemi S, Tehrani FR, Mehrabi Y, Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). J. Obstet. Gynaecol. Res. J Obstet Gynaecol Res. 2013 may; 39(5): 891-897.

https://pubmed.ncbi.nlm.nih.gov/23438323/

85. Hashemi S, Seddigh S, Ramezani Tehrani F, Hasanzadeh Khansari SM, Khodakarami N. Sexual behavior of Married Iranian Women, Attending Taleghani Public Health Center. J Reprod Infertil. 2013 Jan;14(1): 34-38.

https://pubmed.ncbi.nlm.nih.gov/23926559/

86. Rahmani M, Earp MA, Ramezani Tehrani F, Ataee M, Wu J, n Treml M, Nudischer R, P-Behnami S, Consortium R, Perry J R-B, Murabito JM, Azizi F. Angela Brooks-Wilson. Shared genetic factors for age at natural menopause in Iranian and European women. Human Reproduction. 2013 jul; 28(7). 1987-1994.

https://academic.oup.com/humrep/article/28/7/1987/612495

87. Ramezani Tehrani F, Momenan AA, Bahri khomami M, Azizi F. Does lactation protect mothers against metabolic syndrome. Iranian Journal of Diabetes and Lipid Disorders. 2013; 12(1): 47-55.

https://europepmc.org/article/med/24738118

88. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Tahmtan AR. Concerns of Women with Polycystic Ovary Syndrome: A Qualitative Study. Iranian Journal of Endocrinology and Metabolism. 2013; 15 (1): 41-51. 

http://ijem.sbmu.ac.ir/browse.php?a_id=1390&sid=1&slc_lang=en

89. Mehran P, Simbar M, Shams J, Ramezani-Tehrani F, Nasiri N. History of perinatal loss and maternal–fetal attachment behaviors. Women Birth. 2013 Sep;26(3):185-9.

https://pubmed.ncbi.nlm.nih.gov/23721683/

90. Sadat Hosseini M, Ramezani Tehrani F, Azizi F. The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study. Gynecol Endocrinol. 2013 Sep; 29(9): 821-825.

https://pubmed.ncbi.nlm.nih.gov/23782000/

91. Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf). 2014 Jul;81(1):52-7.

https://pubmed.ncbi.nlm.nih.gov/23844634/

92. Lotfi R, Fahimeh Ramezani Tehrani, Farideh Yaghmaei. Social support and HIV prevention among women “at risk”: a qualitative study. Payesh. October-November 2013; 12(5): 537-544 .

https://www.magiran.com/paper/1170930?lang=en

93. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Tahamtan RA. Components of quality of life of women with polycystic ovary syndrome: a qualitative study. Payesh.   Payesh 2013; 12: 657-669.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=333335

94. Tabatabaei M, Zarnani AH, Nikoo Sh, Keshavarzi B, Ramzani Tehrani F, Arefi S,  Mirzadegan E, Mosaffa N. Isolation and Immunophenotypjng of human amniotic epithelial cells. Journal of the faculty of medicine; 2013, 37(1), 1-7.

http://pejouhesh.sbmu.ac.ir/article-1-1144-en.html

95. Khajehpour M, Simbar M, Jannesari S, Ramezani-Tehrani F, Majd HA. Health status of women with intended and unintended pregnancies. Public Health. 2013 Jan;127(1):58-64.

https://pubmed.ncbi.nlm.nih.gov/23200101/

96. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Ghasemi A, Piryaei A, Azizi F. Prenatal testosterone exposure worsen the reproductive performance of male rat at adulthood. PLoS One. 2013 Aug 15;8(8):e71705.

https://pubmed.ncbi.nlm.nih.gov/23967236/

97. Ramezani Tehrani F, Daneshpour M, Hashem S, Zarkesh M,  Azizi F. Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reprod Med. March 2013; 11(3):  185-194.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943219/

98. Ramezani Tehrani F, Minooee S, Simbar M, Azizi F. A Simpler Diagnostic Method to Assess Hirsutism in the Iranian Population: Based on Modified Ferriman- Gallwey Scoring System (a Community Based Study). Iranian Journal of Endocrinology and Metabolism. September 2013; 15(3): 303-310.

http://ijem.sbmu.ac.ir/browse.php?a_id=1507&sid=1&slc_lang=en

99. Maryam F, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Azizi F. Comparison of metabolic changes after natural menopause and surgical menopause. Payesh, November-December 2013; 12(6): 411-416.

http://payeshjournal.ir/article-1-338-en.html

100. Farahmand M, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Azizi F. Comparison of metabolic changes after natural menopause and surgical menopause. Payesh. November-December 2013; 12(6): 411-416.

http://payeshjournal.ir/article-1-338-en.html

101. Hashemi S, Ramezani Tehrani F, Simbar M, Abedini M, Bahreinian H, Gholami R. Evaluation of sexual attitude and sexual function in menopausal age; a population based cross-sectional study. Iran J Reprod Med. August 2013;11(8):631-636.

https://pubmed.ncbi.nlm.nih.gov/24639800/

102. Djalalinia S, Ramezani-Tehrani F, Malekafzali H, Hejazi F, Peykari N. Development and evaluation of a nutritional health program for adolescents. Iran J Nurs Midwifery Res. 2013 Sep;18(5):425-427.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877468/

103. Nasiri Amiri F, Ramezani Tehran F, Simbar M, Mohammadpour Tahamtan RA. Components of quality of life of women with polycystic ovary syndrome: a qualitative study. November-December 2013; 12(6): 413-416.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=333335

104. Ramezani Tehrani F, Behboudi-Gandevani S, Ghanbarian A, Azizi F. Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up, population-based, cohort study. Climacteric. 2014 Apr; 17(2): 164-172.

https://pubmed.ncbi.nlm.nih.gov/23895384/

105. Tabatabaei M, Mosaffa N, Nikoo S, Bozorgmehr M, Ghods R, Kazemnejad S, Rezania S, Keshavarzi B, Arefi S, Ramezani-Tehrani F, Mirzadegan E, Zarnani AH. Isolation and partial characterization of human amniotic epithelial cells: the effect of trypsin. Avicenna J Med Biotechnol. 2014 Jan;6(1):10-20.

https://www.ncbi.nlm.nih.gov/pubmed/24523953

106. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172: 51-5.

https://pubmed.ncbi.nlm.nih.gov/24220143/

107. Hosseinpanah F, Barzin M, Keihani S, Tehrani FR, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol (Oxf). 2014 Jul;81(1):93-9.

https://pubmed.ncbi.nlm.nih.gov/24428207/

108. Ramezani Tehrani F, Minooee S, Azizi F. Validation of a simplified method to assess hirsutism in the Iranian population. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:91-5.

https://pubmed.ncbi.nlm.nih.gov/24393448/

109. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:100-5.

https://pubmed.ncbi.nlm.nih.gov/24411130/

110. Rostami Dovvom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Mehrabi Y. Prevalence of Primary and Secondary Infertility among 18-49 Years Old Iranian Women: a Population-based Study in Four Selected Province. Hakim Medical Journal, 2014(Issue 4). 294-301.

http://hakim.hbi.ir/browse.php?a_id=1200&sid=1&slc_lang=en

111. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Piryaei A, Azizi F. Introducing a rat model of prenatally androgen-induced polycystic ovary syndrome in adulthood. Exp Physiol. 2014 May1; 99(5): 792-801.

https://pubmed.ncbi.nlm.nih.gov/24532600/

112. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Mohammadpour Thamtan RA, Shiva N. Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran. Iran Red Crescent Med J. 2014 Feb;16(2):e12423.

https://pubmed.ncbi.nlm.nih.gov/24719724/

113. Farshchian F, Kazeruni F, Ramezani Tehrani F, Parsian H, Namaki S, Amirrasouli H, Moslemi A, Rahimipour A.  Evaluation of the relationship between serums Visfatin and Resistin levels with BMI in PCOS young women. Journal of Paramedical Sciences (JPS). Spring 2014 5(2): 79-84.

http://journals.sbmu.ac.ir/aab/article/view/5922

114. Hajizadeh S, Vahid Dastjerdi M, Moradi-Lakeh M, Khajavi A, Farzadfar F, Zandian E, Raza O, Tehrani FR, Farzadfar F. The trend of national and subnational burden of maternal conditions in iran from 1990 to 2013: the study protocol. Arch Iran Med. 2014 Mar;17(3):198-203.

https://pubmed.ncbi.nlm.nih.gov/24621364/

115. Ramezani Tehrani F, Momenan AA, Khomami MB, Azizi F. Does lactation protect mothers against metabolic syndrome? Findings from the Tehran Lipid and Glucose Study. J Obstet Gynaecol Res. 2014 Mar;40(3):736-42.

https://pubmed.ncbi.nlm.nih.gov/24738118/

116. Ramezani Tehrani F, Dólleman M, van Disseldorp J, Broer SL, Azizi F, Solaymani-Dodaran M, Fauser BC, Laven JS, Eijkemans MJ, Broekmans F. Predicting menopausal age with anti-Müllerian hormone: a cross-validation study of two existing models. Climacteric. 2014 Oct; 17(5): 583-590.

https://pubmed.ncbi.nlm.nih.gov/24625203/

117. Ramezani Tehrani F, Minooee S, Azizi F. The comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non hirsute women; a population based study. Eur J Endocrinol. 2014 Aug;171(2):199-207.

https://pubmed.ncbi.nlm.nih.gov/24816947/

118. Nasiri Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour Thamtan RA. The experience of women affected by polycystic ovary syndrome: a qualitative study from iran. Int J Endocrinol Metab. 2014 Apr 1;12(2):e13612.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013493/

119. Sevil Hakimi, Masoumeh Simbar, Fahimeh Ramezani Tehrani. Concerns of menopausal women: a phenomenological study in North West Iran. payesh. 2014; 13(3): 321-330.

http://payeshjournal.ir/article-1-304-en.pdf

120. Hashemi S, Ramezani Tehrani F, Farahmand M, Bahri Khomami M. Association of PCOS and Its Clinical Signs with Sexual Function among Iranian Women Affected by PCOS. J Sex Med. 2014 Oct; 11(10): 2508-14.

https://pubmed.ncbi.nlm.nih.gov/24995944/

121. Ramezani Tehrani F, Bahri M, Gholami R, Hashemi S, Nakhoda K, Azizi F. Secular trend of menopausal age and related factors among Tehrani women born from 1930 to 1960; Tehran Lipid and Glucose Study. Arch Iran Med. 2014 Jun;17(6):406-10.

https://pubmed.ncbi.nlm.nih.gov/24916525/

122. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Piryaei A, Hashemi S, Azizi F. The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats. Int J Endocrinol Metab. 2014 Apr 1;12(2):e16502.

https://pubmed.ncbi.nlm.nih.gov/24910644/

123. Farahmand M, Ramezani Tehrani F, Simbar M, Mehrabi Y, Khalili D, Azizi F. Does metabolic syndrome or its components differ in naturally and surgically menopausal women? Climacteric. 2014 Aug;17(4):348-55.

https://pubmed.ncbi.nlm.nih.gov/24188285/

124. Hakimi S, Simbar M, Ramezani Tehrani F. Perceived concerns of azeri menopausal women in iran. Iran Red Crescent Med J. 2014 May;16(5):e11771.

https://pubmed.ncbi.nlm.nih.gov/25031850/

125. Tehrani, F.R, Mirmiran, P, Gholami, R, Moslehi, N, Azizi, F Factors influencing menarcheal age: Results from the cohort of Tehran Lipid and glucose study . International Journal of Endocrinology and Metabolism. 2014 July; 12(3): e16130.

https://pubmed.ncbi.nlm.nih.gov/25237321/

126. Djalalinia, S, Ramezani Tehrani, F, Malekafzali, H, Peykari, N. Peer education: Participatory qualitative educational needs assessment. Iranian Journal of Public Health. Volume 42, Issue 12, 2013, Pages 1422-1429.

https://pubmed.ncbi.nlm.nih.gov/26060644/

127. Ramezani Tehrani, F.a , Mirmiran, P.b , Gholami, R.a , Moslehi, N.b , Ghanbarian, A.d , Azizi, F. Correlation between menarcheal age and certain demographic characteristics. Iranian Journal of Endocrinology and Metabolism. Volume 15, Issue 1, 2013, Pages 52-58.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=339151

128. Ramezani Tehrani F, Farahmand M, Simbar M, Malek Afzali H. Factors Associated with Sexual Dysfunction; A Population Based Study in Iranian Reproductive Age Women. Arch Iran Med. 2014 Oct;17(10):679-684.

https://pubmed.ncbi.nlm.nih.gov/25305767/

129. Tehrani FR, Erfani H, Cheraghi L, Tohidi M, Azizi F. Lipid profiles and ovarian reserve status: a longitudinal study. Hum Reprod. 2014 Nov;29(11):2522-9.

https://pubmed.ncbi.nlm.nih.gov/25267788/

130. Farshchian F, Ramezani Tehrani F, Amirrasouli H, Rahimi Pour H, Hedayati M, Kazerouni F, Soltani A. Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome. Int J Endocrinol Metab. 2014 Jul 1;12(3):e15503.

https://pubmed.ncbi.nlm.nih.gov/25237319/

131. Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014 Sep 16;12:89.

https://pubmed.ncbi.nlm.nih.gov/25224635/

132. Rostami Dovom M, Ramezani Tehrani F, Abedini M, Amirshekari G, Hashemi S, Noroozzadeh M. A population-based study on infertility and its influencing factors in four selected provinces in Iran (2008-2010). Iran J Reprod Med. August 2014, 12( 8); 561-566.

https://pubmed.ncbi.nlm.nih.gov/25408706/

133. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Rostami Dovom M, Azizi F Infertility, the Most Adverse Outcome Among SexualFunction Outcome Affecting of Iranian Women with Polycystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism. August-September 2014,16(3). 197-205.

http://ijem.sbmu.ac.ir/browse.php?a_id=1702&sid=1&slc_lang=en

134. Ramezani Tehrani F, Minooee S, Rostami M, Hashemi S, Azizi F. Determination and Comparison of Estimated Menopausal Age Based on Serum Anti-Mullerian Hormone in Women with and without Polycystic Ovarian Syndrome. Iranian Journal of Endocrinology and Metabolism. October-November 2014, 16(4), 283-289.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=403202

135. Hakimi S, Simbar M, Ramezani Tehrani F. Concerns of menopausal women: a phenomenological study in North West Iran. Journal of the Iranian Institute for Health Sciences ( Payesh). 2014; 13, 321-330.

http://payeshjournal.ir/article-1-304-en.pdf

136. Ramezani Tehrani F, Behboudi-Gandevani S, Simbar M, Azizi . A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances. J Endocrinol Invest. 2014 Sep 9.

https://pubmed.ncbi.nlm.nih.gov/25200999/

137. Tehrani FR, Behboudi-Gandevani S, Ghasemi A, Azizi F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015 Jan;291(1):159-63.

https://pubmed.ncbi.nlm.nih.gov/25200999/

138. Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric. 2014 Oct;17(5):591-7.

https://pubmed.ncbi.nlm.nih.gov/24716733/

139. Amiri P, Amouzegar A, Gharibzadeh S, Kazemian E, Ramezani Tehrani F, Azizi F. Socio-behavioral and reproductive determinants associated with contraceptive method choice among Tehranian women: Tehran Lipid and Glucose Study. Pejouhesh. 2014; 38 (2) :111-119.

http://pejouhesh.sbmu.ac.ir/browse.php?a_id=1341&sid=1&slc_lang=en

140. Keshavarzi B, Zarnani A, Bozorgmehr M, Tabatabai M, Mirzadegan E, Ramezani Tehrani F, et al . The study of tollerogenic effect of human amniotic epithelial cells co-culture with monocyte derived dendritic cells . Pejouhesh. 2014; 38 (2) :65-78.

http://pejouhesh.sbmu.ac.ir/browse.php?a_id=1335&sid=1&slc_lang=en

141. Razieh Lotfi , Fahimeh Ramezani Tehrani, Farideh Yaghmaei , Ebrahim Hajizadeh. Developing a Valid and Reliable Instrument to Predict the Protective Sexual Behaviors in Women at Risk of Human Immunodeficiency Virus. Iran Red Crescent Med J. 2014 September; 16(9).

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270666/

142. Soheila Nazarpour, Masome Simbar, Fahimeh Ramezani Tehrani. Factors affecting sexual function during menopause: a review of the literature. Payesh. 2015, 14(1): 41-58.

https://www.sciencedirect.com/science/article/pii/S1028455916300602

143. Keshavarzi B, Zarnani A, Bozorgmehr M, Tabatabai M, Mirzadegan E, Ramezani Tehrani F, et al . The study of tollerogenic effect of human amniotic epithelial cells co-culture with monocyte derived dendritic cells . Pejouhesh. 2014; 38 (2) :65-78.

http://pejouhesh.sbmu.ac.ir/browse.php?a_id=1335&sid=1&slc_lang=en

144. Rostami Dovom M, Ramezani Tehrani F, Amiri P, Amirshekari G, Farahmand M, Azizi F. Main facilitators of smoking among young males in tehran: tehran lipid and glucose study. Iran Red Crescent Med J. 2014 Sep 5;16(9):e15429.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270672/

145. Rostami Dovom M , Ramezani Tehrani F , Farahmand M , Hashemi S , Rezaee N , Azizi F . Prevalence of Menstrual Disorders and its Related Factors in 18-45 year-old Iranian Women in Four Selected Provinces . Hakim. 2014; 17 (3) :192-199.

http://hakim.hbi.ir/article-1-1365-en.pdf

146. Lotfi R, Tehrani FR, Dovom MR, Torkestani F, Abedini M, Sajedinejad S. Development of strategies to reduce cesarean delivery rates in iran 2012-2014: a mixed methods study. Int J Prev Med. 2014 Dec;5(12):1552-66.

https://pubmed.ncbi.nlm.nih.gov/25709791/

147. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Rostami Dovom M, Noroozzadeh M, Azizi F. The Prevalence of Various Phenotypes of Polycystic Ovary Syndrome: a Community-Based Study in Southwest of Iran. Iranian Journal of Endocrinology and Metabolism. June-July 2014; 16(2): 119-126.

http://ijem.sbmu.ac.ir/browse.php?a_id=1615&sid=1&slc_lang=en

148. Nazarpour S; Ramezani Tehrani F; Simbar M; Azizi F. Pregnancy outcomes in pregnant women with hypothyroidism (A review Article). IJOGI, Nov 2014l 17(126): 17-26.

http://eprints.mums.ac.ir/4043/

149. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. The association between duration of oral contraceptive pills consumption with metabolic syndrome: tehran lipid and glucose study. Iranian Journal of Doabetes and Metabolism. 2014; 14 (1) :37-46.

https://ijdld.tums.ac.ir/browse.php?a_id=5319&sid=1&slc_lang=en

150.  Tehrani, F.R, Behboudi-Gandevani, S, Ghasemi, A, Azizi, F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet. 2015 Jan;291(1):159-63.

https://pubmed.ncbi.nlm.nih.gov/25200999/

151. Lotfi R,  Ramezani Tehrani F, Farahnaz Torkestani F, Rostami Dovom M,  Abedini M, Sima Sajedinejad S. Health system management and strategies to decrease elective cesarean section: a qualitative study. January-February 2015; 14(1): 629-636.

https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=411401

152. Nazarpour  S,  Simbar M, Ramezani Tehrani F. Factors affecting sexual function during menopause: a review of the literature. Payesh. January-February 2015; 14(1): 41-58.

http://payeshjournal.ir/article-1-255-en.html

153. Farahmand M, Ramezani Tehrani F, Noroozzadeh M, Azizi F.  The relationship between some risk factors of cardiovascular diseases in reproductive age women with duration of oral contraceptive pills use. Feb 2015; 24(4):  242-247.

http://tmuj.iautmu.ac.ir/article-1-874-en.html

154. Peykari N, Eftekhari MB, Tehrani FR, Afzali HM, Hejazi F, Atoofi MK, Qorbani M, Asayesh H, Djalalinia S. Promoting physical activity participation among adolescents: The barriers and the suggestions. Int J Prev Med. 2015 Feb 20;6:12.

https://pubmed.ncbi.nlm.nih.gov/25789144/

155. Lotfi R, Ramezani Tehrani F, Yaghmaei F, Hajizadeh E. Developing a valid and reliable instrument to predict the protective sexual behaviors in women at risk of human immunodeficiency virus. Iran Red Crescent Med J. 2014 Sep 5;16(9):e14682.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270666/

156. Farahmand M, Amiri P, Ramezani Tehrani F, Momenan AA, Mirmiran P, Azizi F. What are the main barriers to healthy eating among families? A qualitative exploration of perceptions and experiences of Tehranian men. Appetite. 2015 Jun 1;89:291-7.

https://pubmed.ncbi.nlm.nih.gov/25725485/

157. Daneshian Z, Ramezani Tehrani F, Zarkesh M, Norooz Zadeh M, Mahdian R, Zadeh Vakili A. Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats. Int J Endocrinol Metab. 2015 Jan 30;13(1):e19511.

https://pubmed.ncbi.nlm.nih.gov/25745494/

158. Minooee S, Ramezani Tehrani F, Mirmiran P, Azizi F. The Association between Birth Weight and Adulthood Body Fat Mass in Women with Poly Cystic Ovary Syndrome. Iranian Journal of Endocrinology and Metabolism. February-March 2015. 16(6);  441-447.

http://ijem.sbmu.ac.ir/browse.php?a_id=1764&sid=1&slc_lang=en

159. Simbar, M, Shadipour, M,  Salamzadeh, J,  Ramezani-Tehrani, F,  Nasiri, N. The combination of "pimpinella anisum, Apium graveolens and Crocus sativus (PAC)" is more effective than "mefenamic acid" on postpartum after-pain. Journal of Herbal Medicine. March 2015; 5(1): 20-25.

https://www.sciencedirect.com/science/article/pii/S2210803315000056

160. Ramezani Tehrani, F,  Minooee, S,  Rostami, M,  Hashemi, S,  Azizi, F. Determination and comparison of estimated menopausal age based on serum anti-mullerian hormone in women with and without polycystic ovarian syndrome. Iranian Journal of Endocrinology and Metabolism. October-november 2014. 16(4), 283-289.

http://ijem.sbmu.ac.ir/browse.php?a_id=1643&sid=1&slc_lang=en

161. Fahimeh Ramezani Tehrani , Sonia Minooee, Masoumeh Simbar , Fereidoun Azizi. visceral adiposity index (vai), as the best predictor of insulin resistance and metablis syndrome in the women with polycystic ovary syndrome. Inranian journal of Diabetes and Metabolism. 2015. 14(2): 117-128.

https://ijdld.tums.ac.ir/browse.php?a_id=5350&sid=1&slc_lang=en

162. Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F. Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand. 2015 Jul;94(7):708-714.

https://pubmed.ncbi.nlm.nih.gov/25867606/

163. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaei S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials.  Iran J Reprod Med. January 2015; 13(1): 1-8.

https://pubmed.ncbi.nlm.nih.gov/25653669/

164. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F. Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women. PLoS One. 2015 Apr 15;10(4):e0123608.

https://pubmed.ncbi.nlm.nih.gov/25874409/

165. Kazemi H, Ramezani Tehrani F, Minooee S, Khalili D, Azizi F. Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study. Endocrinol Invest. 2015 Aug;38(8):923-8.

https://pubmed.ncbi.nlm.nih.gov/25740069/

166. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Noroozzadeh M, Azizi F. Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study. J Endocrinol Invest. 2015 Jul;38(7):761-7.

https://pubmed.ncbi.nlm.nih.gov/25722224/

167. Noroozzadeh M, Ramezani Tehrani F, Sedaghat K, Godini A, Azizi F. The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat's offspring in adulthood. J Endocrinol Invest. 2015 May;38(5):489-95.

https://pubmed.ncbi.nlm.nih.gov/25527160/

168. Nazarpour S, Simbar M, Ramezani Tehrani F, Tohidi M, Alavi Majd H. Study on the Correlation between Serum Androgens and Sexual Function in Post-menopausal Women Iranian Journal of Endocrinology and Metabolism April-May 2015. 17)1(: 13-22.

http://ijem.sbmu.ac.ir/browse.php?a_id=1869&sid=1&slc_lang=en

169. Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials. Iran J Reprod Med. 2015 Jan;13(1):1-8.

https://pubmed.ncbi.nlm.nih.gov/25653669/

170. Ehsani B, Moslehi N, Ramezani Tehrani F, Mirmiran P, Azizi F. Relationship between Dietary Pattern and Cardiometabolic Risk Factors in Women with PCOS. Iranian Journal of Endocrinology and Metabolism. 2015; 17 (1) :33-43.

http://ijem.sbmu.ac.ir/browse.php?a_id=1875&sid=1&slc_lang=en

171. Djalalinia S, Ramezani Tehrani F, Malekafzali H, Hashemi Z, Peykari N. A youth-led reproductive health program in a university setting. Med J Islam Repub Iran. 2015; 29 (0) :210-0.

http://mjiri.iums.ac.ir/browse.php?a_id=2886&sid=1&slc_lang=en

172. Nazarpour S, Simbar M, Ramezani Tehrani F. Effects of the severity of menopausal symptoms on sexual function in postmenopausal women. The Journal of Qazvin University of Medical Sciences. 2015; 19 (4) :63-54.

http://journal.qums.ac.ir/browse.php?a_id=1869&sid=1&slc_lang=en

173. Nazarpour S, Simbar M, Ramezani Tehrani F. androgens and sexual function during menopause. Urmia Medical Journal. 2015; 26 (2) :135-147

174. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani A. Comparison of energy-restricted high protein (HP) with standard-protein (SP) diets in women with polycystic ovary syndrome. MEDICAL SCIENCES. 2015; 25 (2) :95-104.

https://www.sid.ir/en/Journal/ViewPaper.aspx?ID=438787

175. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. The Prevalence of Menstrual Disorders in Reproductive Aged Women and its Related Factors. Iranian Journal of Endocrinology and Metabolism. 2015; 17 (2) :105-112.

http://ijem.sbmu.ac.ir/browse.php?a_id=1898&sid=1&slc_lang=en

176. Ramezani Tehrani F. Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis.  Int J Endocrinol Metab 2015 July; 13(3): e28557.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Polycystic+Ovary+Syndrome%3A+An+Apparently+Simple+yet+Challenging+Diagnosis

177. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Exercise and sexual dysfunction among postmenopausal women in Iran. Scientific Journal of School of Public Health and Institute of Public Health Research. Spring 2015; 13(1): 17-32.

https://sjsph.tums.ac.ir/browse.php?a_id=5241&sid=1&slc_lang=en

178. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci. 2015 Apr 19;7(6):45001.

https://pubmed.ncbi.nlm.nih.gov/26153187/

179. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016 Mar;39(3):277-83.

https://pubmed.ncbi.nlm.nih.gov/26223383/

180. Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid autoantibodies and the effect on pregnancy outcomes. J Obstet Gynaecol. 2016;36(1):3-9.

https://pubmed.ncbi.nlm.nih.gov/26203920/

181. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest. 2016 Mar;39(3):277-83.

https://pubmed.ncbi.nlm.nih.gov/26223383/

182. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H , Azizi F. Mimetical Signs and Symptoms of Thyroid Disorders in Healthy Pregnant Women, a Population Based Study. Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2015; Vol 17 No.3: 181-189.

http://ijem.sbmu.ac.ir/browse.php?a_id=1922&sid=1&slc_lang=en

183. Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, Cheraghi L, Erfani H, Tohidi M, Azizi F. Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study. PLoS One. 2015 Sep 11;10(9):e0137609.

https://pubmed.ncbi.nlm.nih.gov/26360602/

184. Depmann M, Broer SL, van der Schouw YT, Tehrani FR, Eijkemans MJ, Mol BW, Broekmans FJ. Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review. Menopause. 2016 Feb;23(2):224-32.

https://www.ncbi.nlm.nih.gov/pubmed/26372034

185. Maryam Rostami, Fahimeh Ramezani Tehrani, Masoomeh Simbar , Farhad Hossein Panah, Hamid Alavi Majd. Prevalence of Vitamin D deficiency and Affecting factors Among Pregnant Women in the First Trimester in Masjed Soleimam,Iran IJOGI, Vol. 18, No. 164, pp. 1-10, Sep 2015.

http://eprints.mums.ac.ir/3034/

186. Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid dysfunction and pregnancy outcomes. Iran J Reprod Med. 2015 Jul;13(7):387-96. Review.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609317/

187. Nazarpour S, Tehrani FR, Simbar M, Tohidi M, AlaviMajd H, Azizi F. Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. Eur J Endocrinol. 2016 Jan;174(1):77-83.

https://pubmed.ncbi.nlm.nih.gov/26510839/

188. Ehsani B, Moslehi N, Mirmiran P, Ramezani Tehrani F, Tahmasebinejad Z, Azizi F. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Clin Nutr. 2015 Nov 25. pii: S0261-5614(15)00261-7.

https://pubmed.ncbi.nlm.nih.gov/26699405/

189. Minooee S, Ramezani Tehrani F, Azizi F. Hirsutism region and the likelihood of metabolic syndrome: is there a link? Endocrine. 2016 Aug;53(2):607-9.

https://pubmed.ncbi.nlm.nih.gov/26668059/

190. Lotfi R, Ramezani Tehrani F, Salehifar D, Dworkin SL. Erratum to: Predictors of Condom Use Among Iranian Women at Risk of HIV. Arch Sex Behav. 2016 Feb;45(2):439.

https://www.ncbi.nlm.nih.gov/pubmed/26621150

191. Lotfi R, Ramezani Tehrani F, Salehifar D, Dworkin SL. Predictors of Condom Use Among Iranian Women at Risk of HIV. Arch Sex Behav. 2016 Feb; 45(2): 429-37.
192. Hakimi S, Simbar M, Ramezani Tehrani F, Zaiery F, Khatami S. Women's perspectives toward menopause: A phenomenological study in Iran. J Women Aging. 2016;28(1):80-9.

https://pubmed.ncbi.nlm.nih.gov/26735699/

193. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Sexual Function and Exercise in Postmenopausal Women Residing in Chalous and Nowshahr, Northern Iran. Iran Red Crescent Med J. 2016 Jan 20;18(5):e30120.

https://sites.kowsarpub.com/ircmj/articles/16742.html

194. Nasiri-Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour RA. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties. Qual Life Res. 2016 Jul;25(7):1791-801.

https://pubmed.ncbi.nlm.nih.gov/26814480/

195. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Steyerberg E, Azizi F. Flexible parametric survival models built on age-specific antimu¨llerian hormone percentiles are better predictors of menopause. Menopause. 2016 Jun;23(6):676-81.

https://pubmed.ncbi.nlm.nih.gov/27023864/

196. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. The impact of a sexual enhancement program on the sexual function of postmenopausal women. Climacteric. 2016 Oct;19(5):506-11.

https://europepmc.org/article/med/27631563

197. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Azizi F. Tehran thyroid and pregnancy study: objectives and study protocol. Int J Endocrinol Metab. 2016 Jan 30;14(1):e33477.

https://pubmed.ncbi.nlm.nih.gov/27279833/

198. Behboudi-Gandevani S,  Ramezani Tehrani F,  Rostami Dovom M,  Farahmand M,  Bahri Khomami M,  Noroozzadeh M,  Kabir A,  Azizi F. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343-53.

https://pubmed.ncbi.nlm.nih.gov/27052492/

199. Abdi F, Mobedi PharmD H, Mosaffa N, Dolatian M, Ramezani Tehrani F. Hormone Therapy for Relieving Postmenopausal Vasomotor Symptoms: A Systematic Review. Arch Iran Med. 2016 Feb;19(2):141-6.

https://www.ncbi.nlm.nih.gov/pubmed/26838086

200. Hajizadeh S, Tehrani FR, Simbar M, Farzadfar F. Effects of Recruiting Midwives into a Family Physician Program on Women's Awareness and Preference for Mode of Delivery and Caesarean Section Rates in Rural Areas of Kurdistan. PLoS One. 2016 Apr 8;11(4):e0151268.

https://pubmed.ncbi.nlm.nih.gov/27058952/

201. Hajizadeh S, Ramezani Tehrani F, Simbar M, Farzadfar F. Effects of Recruiting Midwives into a Family Physician Program on the Indices of Maternal Health Program in the Rural Areas of Kurdistan. Glob J Health Sci. 2016 Mar 1;8(11):53539.

http://www.ccsenet.org/journal/index.php/gjhs/article/view/53539

202. Tehrani FR, Zarkesh M, Tohidi M, Azizi F, Zadeh-Vakili A. Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status? Reprod Fertil Dev. 2017 Apr;29(4):670-678.

https://www.publish.csiro.au/RD/RD15157

203. Amini L., Tehranian N., Movahedin M., Ramezani Tehrani F. Effect of calligonum comosum on ovarian histology of polycystic ovary mouse model. Journal of Medicinal Plants;   december 2015; 14(56): 115-122.

http://jmp.ir/browse.php?a_id=1231&sid=1&slc_lang=en

204. Amiri, M., Mirmiran, P., Ramezani Tehrani, F. Effect of interventions based on lifestyle modification on clinical, hormonal and metabolic findings in the patients with polycystic ovary syndrome: A systematic review. Iranian Journal of Endocrinology and Metabolism. 2016, 17(6): 489-500.

http://ijem.sbmu.ac.ir/browse.php?a_id=1993&slc_lang=en&sid=1&printcase=1&hbnr=1&hmb=1

205. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Sexual dysfunction and the underlying medical problems in post-menopausal women. Tehran Univ Med J. 2016; 73 (11) :798-811.

https://tumj.tums.ac.ir/browse.php?a_id=7192&sid=1&slc_lang=en#:~:text=Conclusion%3A%20Cardiovascular%20disorders%2C%20diabetes%2C,health%2C%20particularly%20their%20sexual%20function.

206. Masoumeh Simbar; Fatemeh Rahmanian; Fahimeh Ramezani Tehrani. Explaining the experiences and perceptions of gynecologists and midwives about virginity examination and it’s outcomes: A qualitative Study. The Iranian Journal of Obstetrics, Gynaecology and Infertility. Autumn 2015; 18(173): 1-40.

http://eprints.mums.ac.ir/2967/

207. Gohari MR, Ramezani Tehrani F, Chenouri SH, Solaymani-Dodaran M, Azizi F. Individualized predictions of time to menopause using multiple measurements of antimu¨llerian hormone. Menopause. 2016 Aug;23(8):839-45.

https://pubmed.ncbi.nlm.nih.gov/27326817/

208. Abdi F, Mobedi H, Mosaffa N,. Dolatian M & Ramezani Tehrani F. Effects of hormone replacement therapy on immunological factors in the postmenopausal period. Climacteric, 2016; 19(3): 234–239.

https://www.ncbi.nlm.nih.gov/pubmed/27086591

209. Abdi F, Kazemi F, Ramezani Tehrani F, Roozbeh N. Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms. BMJ Open. 2016 Apr 22;6(4):e010734.

https://bmjopen.bmj.com/content/6/4/e010734

210. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR, Moslehi N. Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls. Glob J Health Sci. 2016 Feb 2;8(9):54801.

https://www.ncbi.nlm.nih.gov/pubmed/27157182

211. Bahri Khomami M, Ramezani Tehrani F, Hashemi S, Mohammadi N, Rashidi H, Azizi F. Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study. Hum Reprod. 2016 Jun;31(6):1339-46.

https://www.ncbi.nlm.nih.gov/pubmed/2707650

212. Noroozzadeh M, Ramezani Tehrani F, Zadeh Vakili A, Piryaei A, Azizi F. The effect of intrauterine injection of androgen on reproductive system and hormonal changes in adult female rat's offspring. Iranian Journal of Physiology and Pharmacology. Summer 2015; 1(2): 68-76.

http://ijpp.phypha.ir/article-1-256-en.html

213. Ramezani Tehrani F, Bahri Khomami M, Amouzegar A, Azizi F Thyroperoxidase antibodies and polycystic ovarian morphology. Int J Gynaecol Obstet. 2016 May 4. pii: S0020-7292(16)30112-6.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Thyroperoxidase+antibodies+and+polycystic+ovarian+morphology

214. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani A R, Moslehi N. Factors Influencing Physical Activity in Women with Polycystic Ovary Syndrome in Comparison to Eumenorrheic Non Hirsute Women. Global Journal of Health Science. Feb 2016; 8(10):  127-134.

https://pubmed.ncbi.nlm.nih.gov/27302456/

215. Ramezani Tehrani F, Montazeri SA, Khalili D, Cheraghi L, Broekmans FJ, Momenan AA, de Kat AC, Azizi F. Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease. Climacteric. 2016 Aug;19(4):344-8.

https://pubmed.ncbi.nlm.nih.gov/27174310/

216. Minooee S, Ramezani Tehrani F, Mirmiran P, Azizi F. Low birth weight may increase body fat mass in adult women with polycystic ovarian syndrome. Int J Reprod BioMed.  May 2016; 14(5): 335-340.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910034/

217. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Azizi F. Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol. Int J Endocrinol Metab. 2016 Jan 30;14(1):e33477.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895998/

218. Salehi Jahromi M, Ramezani Tehrani F, Zadeh-Vakili A. The Effects of Prenatal Excess Androgens Exposure on the Gene Expression. Iranian Journal of Endocrinology and Metabolism. 2016; 18 (4) :303-313.

http://ijem.sbmu.ac.ir/browse.php?a_id=2122&sid=1&slc_lang=en

219. Rezayat F, Hajiaghayi M, Ramezani Tehrani F, Mosaffa N. Increase Risk of Ovarian and Breast Cancers in Women with PolyCystic Ovarian Syndrome: a Review. Iranian Journal of Endocrinology and Metabolism. April-May 2016; 18 (1): 54-62.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=510704

220. Nazarpour S, Ramezani Tehrani  F, Simbar M, Tohidi M. Comparison of universal screening with targeted high-risk case finding of thyroid disorders in pregnant women. The Quarterly journal of School of Medicine, Shahid Beheshti University of Medical Sciences. 2015; 39(3): 145-151.

https://pubmed.ncbi.nlm.nih.gov/26510839/

221. Hajizadeh Sh, Ramezani Tehrani F, Simbar M, Farzadfar F. Factors affecting pregnancy, postpartum and neonatal complications in rural areas of Kurdistan Province, Iran. Scientific Journal of School of Public Health and Institute of Public Health Research. Spring 2015; 13(3): 19-36.

https://sjsph.tums.ac.ir/browse.php?a_id=5299&sid=1&slc_lang=en

222. Hashemi S, Ramezani Tehrani F, Mohammadi N, Rostami Dovom M, Torkestani F, Simbar M, & Azizi F. Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study. International Journal of Endocrinology and Metabolism. 14(2): e28422.

https://pubmed.ncbi.nlm.nih.gov/27679647/

223. Rashidi H, Sharif Najafi A, Kaykhaei MA, Latifi SM, Ramezani Tehrani F, Shahbazian H. Association of thyroid stimulating hormone in women with poly cystic ovary syndrome and non poly cystic ovary syndrome with insulin resistance. International Journal Of Pharmacy & Technology. June 2016; 8(2): 11634-11642.

http://www.ijptonline.com/wp-content/uploads/2016/07/11634-11642.pdf

224. Jahromi MS, Tehrani FR, Noroozzadeh M, Zarkesh M1, Ghasemi A, Zadeh-Vakili A. Elevated expression of steroidogenesis pathway genes; CYP17, GATA-6 and StAR in prenatally androgenized rats Gene. 2016 Nov 15;593(1):167-71.

https://pubmed.ncbi.nlm.nih.gov/27511375/

225. Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, Azizi F. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol. 2016 Aug 9;205:110-114.

https://pubmed.ncbi.nlm.nih.gov/27579518/

226. Salehifar D, Lotfi R, Ramezani Tehrani F. The Comparative Study of Depression in Women with Polycystic Ovary Syndrome and Control Group. Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2016; 18(3): 180-186.

http://ijem.sbmu.ac.ir/article-1-2079-en.pdf

227. Hajiaghayi M, Rezayat F, Ghasemi N, Mesdaghi M, Soleymanian A, Mosaffa N, RamezaniTehrani F. The Study of cell Proliferation, TNF- Cytokine Production and Expression of CD8 Marker in Peripheral Blood Lymphocytes of Women with Polycystic Ovary Syndrome (PCOS) by co-culture with Ovarian Tumor Cell Lines (SKOV3,A2780). Iranian Journal of Endocrinology and Metabolism. Aug-Sep 2016; 18(3): 180-186.

http://ijem.sbmu.ac.ir/article-1-2080-en.pdf

228. Rezayat F, Hajiaghaei M, Mosaffa N, Ramezani Tehrani F, Mesdaghi M. The Study of Peripheral Blood Mononuclear Cells Activity of Women with Polycystic Ovary Syndrome (PCOS) by coculture with Breast Cancer Cell Lines Compared with the Healthy Controls. Iranian Journal of Endocrinology and Metabolism. June-July 2016; 18(2): 120-127.

http://ijem.sbmu.ac.ir/browse.php?a_id=2055&sid=1&slc_lang=en

229. Ghasemi N, Ramezani Tehrani F, Mosaffa N. Effects of Nulliparity and Multiparity on Probability of Breast Tumor Incidences: A review. Iranian Journal of Endocrinology and Metabolism. June-July 2016; 18(2): 128-134.

http://ijem.sbmu.ac.ir/browse.php?a_id=2030&sid=1&slc_lang=en

230. Noroozzadeh M, Tehrani FR, Mobarakabadi SS, Farahmand M, Dovom MR. Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study. Int J Impot Res. 2017 Jan;29(1):1-6.

https://www.nature.com/articles/ijir201635?proof=trueSouthampton

231. Nazarpour S, Simbar M, Tehrani FR. Factors affecting sexual function in menopause: A review article. Taiwan J Obstet Gynecol. 2016 Aug;55(4):480-7.

https://pubmed.ncbi.nlm.nih.gov/27590367/

232. Shishehgar F, Ramezani Tehrani F, Mirmiran P, Hajian S, Baghestani AR. Comparison of the Association of Excess Weight on Health Related Quality of Life of Women with Polycystic Ovary Syndrome: An Age- and BMI-Matched Case Control Study. PLoS One. 2016 Oct 13;11(10):e0162911.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Comparison+of+the+Association+of+Excess+Weight+on+Health+Related+Quality+of+Life+of+Women+with+Polycystic+Ovary+Syndrome%3A+An+Age-+and+BMI-Matched+Case+Control+Study

233. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M4 Alavi Majd H, Azizi F. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017 Feb;176(2):253-265.

https://pubmed.ncbi.nlm.nih.gov/27879326/

234. Farahmand M, Tehrani FR, Dovom MR, Azizi F. Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study. J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):156-162.

https://pubmed.ncbi.nlm.nih.gov/27840328/

235. Rostami Dovom M, Ramezani Tehrani F, Djalalinia SH, Cheraghi L, Behboudi Gandavani S, Azizi F. menstrual cycle irregularity and metabolic disorders: a population-based prospective study. PLoS One. 2016 Dec 16;11(12):e0168402.

https://pubmed.ncbi.nlm.nih.gov/27992506/

236.  Rostami Dovom M, Ramezani Tehrani F,  Nazeri P,  Alamdari SH, Azzizi F. Using a Scientific Map to Compare Scientific Publications on Poly Cystic Ovary Syndrome in Iran, Middle East and Other Countries. Iranian Journal of Endocrinology and Metabolism. 2016; 18 (4) :287-296.

http://ijem.sbmu.ac.ir/browse.php?a_id=2090&sid=1&slc_lang=en

237. Ghasemi N, Hajiaghayi M, Rezayat F, Mesdaghi M, Mosaffa N, Ramezani Tehran F. Expression of CD8 marker and proliferation of peripheral blood lymphocyte of multiparous women by Co-culture with breast tumor cell, MDA-231 and MCF-7 lines and comparison with nulliparous women. The Iranian Journal of Obstetrics, Gynecology and Infertility. Summer 2016; 19(20): 8-18.

https://www.sid.ir/en/journal/ViewPaper.aspx?id=522604

238. Hashemi  S, Ramezani Tehrani F, Bahry Khomami M, Azizi F. In Vitro Diagnostic Criterion of Androgen Excess in Polycystic Ovary Syndrome: A Community Based Study on Iranian Reproductive Aged Women. Medical Journal of Tabriz University of Medical Sciences and Health Services. Oct. – Nov. 2016; 38(4): 84-89.

https://www.semanticscholar.org/paper/In-Vitro-Diagnostic-Criterion-of-Androgen-Excess-in-Hashemi-Tehrani/10515eef9059a7bda95fcb0470729b99e45d3559

239. Noroozzadeh M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. A Comparison of Sexual Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During Their Pregnancy Period with Those Without PCOS. Arch Sex Behav. 2017 Oct;46(7):2033-2042.

https://pubmed.ncbi.nlm.nih.gov/28070801/

240. Salehi Jahromi, M.Ramezani Tehrani, F, Zadeh-Vakili, A. The effects of prenatal excess androgens exposure on the gene expression. I ranian Journal of Endocrinology and Metabolism. Dec 2016; 18(4): 303-313.

http://ijem.sbmu.ac.ir/browse.php?a_id=2122&sid=1&slc_lang=en

241. Nazarpour S8, Simbar M, Ramezani Tehrani F, Alavi Majd H. Relationship between Sexual Function and Quality of Life in Post-menopausal Women. J Mazandaran Univ Med Sci. 2016; 26(143): 88-98.

http://jmums.mazums.ac.ir/browse.php?a_id=8999&sid=1&slc_lang=en

242. Abdi F, Ramezani Tehrani F, Mobedi H, Dolatian M, Mosaffa N. Nanomedicine Approaches for Treatment of Menopausal Symptoms. J Menopausal Med. 2016 Dec;22(3):127-128.

https://pubmed.ncbi.nlm.nih.gov/28119890/

243. Abdi F, Mobedi H, Bayat F, Mosaffa N, Dolatian M, RamezaniTehrani F. The Effects of Transdermal Estrogen Delivery on Bone Mineral Density in Postmenopausal Women: A Meta-analysis.  Iranian Journal of Pharmaceutical Research. 2017; 16 (1): 380-389.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423263/

244. Salehi Jahromi M, Ramezani Tehrani F, Hill JW, Noroozzadeh M, Zarkesh M, Ghasemi A, Zadeh-Vakili A. Alteration in follistatin gene expression detected in prenatally androgenized rats. Gynecol Endocrinol. 2017 Jun;33(6):433-437.

https://pubmed.ncbi.nlm.nih.gov/28277126/

245. Daneshpour MS, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AA, Ghanbarian A, Amouzegar A, Amiri P, Azizi F. Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc. 2017 Feb 23;6(2):e28.

https://pubmed.ncbi.nlm.nih.gov/28232301/

246. Minooee S, Ramezani Tehrani F, Tohidi M, Azizi F. Role of androgen ratios in the prediction of the metabolic phenotype in polycystic ovary syndrome. Int J Gynaecol Obstet. 2017 May;137(2):110-115.

https://pubmed.ncbi.nlm.nih.gov/28244213/

247. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Diabetes incidence and influencing factors in women with and without gestational diabetes mellitus: A 15year population-based follow-up cohort study. Diabetes Res Clin Pract. 2017 Apr 8;128:24-31.

https://pubmed.ncbi.nlm.nih.gov/28432896/

248. Simbar M, Aarabi Z, Keshavarz Z, Ramezani-Tehrani F, Baghestani AR. "Promotion of physical activity of adolescents by skill-based health education". Health Education. 2017, 117(2): 207-214.

https://www.emerald.com/insight/content/doi/10.1108/HE-09-2016-0037/full/html

249. Behboudi-Gandevani S, Ramezani Tehrani F*, Cheraghi L, Noroozzadeh M, Farahmand M, Azizi F. Trends of contraception use among married reproductive age women: Tehran lipid and glucose cohort study 2002-2011. Sex Reprod Healthc. 2017 Jun;12:116-122.

https://pubmed.ncbi.nlm.nih.gov/28477923/

250. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism clinical and experimental. Aug 2017; 73: 22-35. (IF= 4.375)

https://pubmed.ncbi.nlm.nih.gov/28732568/

251. Rostami M, Ramezani Tehrani F, Simbar M, Hosseinpanah F, Alavi Majd H. Rationale and Design of Khuzestan Vitamin D Deficiency Screening Program in Pregnancy: A Stratified Randomized Vitamin D Supplementation Controlled Trial. JMIR Res Protoc. 2017 Apr 7;6(4):e54.

https://pubmed.ncbi.nlm.nih.gov/28389419/

252. Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest. 2017 Aug;40(8):859-866. IF=1.994

https://pubmed.ncbi.nlm.nih.gov/28332170/

253. Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017 Sep;87(3):217-230.

https://pubmed.ncbi.nlm.nih.gov/28575537/

254. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Effects of Sex Education and Kegel Exercises on the Sexual Function of Postmenopausal Women: A Randomized Clinical Trial. J Sex Med. 2017 Jul;14(7):959-967.

https://pubmed.ncbi.nlm.nih.gov/28601506/

255. Moslehi N, Mirmiran P, Tehrani FR, Azizi F. Current Evidence on Associations of Nutritional Factors with Ovarian Reserve and Timing of Menopause: A Systematic Review. Adv Nutr. 2017 Jul 14;8(4):597-612. (IF= 5.233)

https://www.ncbi.nlm.nih.gov/pubmed/?term=Current+Evidence+on+Associations+of+Nutritional+Factors+with+Ovarian+Reserve+and+Timing+of+Menopause%3A+A+Systematic+Review

256. M. Depmann, M.J.C. Eijkemans, S.L. Broer, A. de Kat, F. Ramezani Tehrani, M. olaymani Dodaran, F. Azizi, M. Solaymani, J.F. Randolph JR, S.D. Harlow, E.W. Freeman, M.D. Sammel, M. Wellons, W.M.M. Verschuren, Y.T. van der Schouw, B.W. Mol, F.J.M. Broekmans. How well does AMH relate to the timing of menopause? Results of an individual patient data meta-analysis. Maturitas. June 2017; 100: 201. (IF= 3.255)

https://www.ncbi.nlm.nih.gov/pubmed/?term=How+well+does+AMH+relate+to+the+timing+of+menopause%3F+Results+of+an+individual+patient+data+meta-analysis

257. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Minooee S, Azizi F. Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study. PLoS One. 2017 Jul 17;12(7):e0179634. (IF= 2.806)

https://www.ncbi.nlm.nih.gov/pubmed/?term=Serum+variations+of+anti-mullerian+hormone+and+total+testosterone+with+aging+in+healthy+adult+Iranian+men%3A+A+population-based+study

258. Farahmand M, Ramezani Tehrani F, Khalili D, Amin G, Negarandeh R. Factors associated with the severity of premenstrual syndrome among Iranian college students. J Obstet Gynaecol Res. 2017 Nov;43(11):1726-1731.(IF=1.086)

https://pubmed.ncbi.nlm.nih.gov/28737241/

259. Simbar M, Aarabi Z, Keshavarz Z, Ramezani Tehrani F, Baghestani A.R. Promotion of physical activity of adolescents by skill-based health education.  Health Education. 2017; 117(2): 207-214.

https://www.emerald.com/insight/content/doi/10.1108/HE-09-2016-0037/full/html

260. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep 29;6(9):e191.

https://pubmed.ncbi.nlm.nih.gov/28963092/

261. Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Noroozzadeh M, Farahmand M, Rostami Dovom M, Ramezani Tehrani F. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Clin Endocrinol (Oxf). 2018 Feb;88(2):169-184. (IF=3.327)

https://pubmed.ncbi.nlm.nih.gov/28930378/

262. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study. Endocrine. 2017 Nov;58(2):228-235.

https://pubmed.ncbi.nlm.nih.gov/28884288/

263. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Arch Iran Med. 2017 Sep;20(9):558-563.

https://pubmed.ncbi.nlm.nih.gov/29048917/

264.  Behboudi-Gandevani S. Ramezani Tehrani F Rostami Dovoom M, Azizi F. Population policies and contraception use behavior: Tehran Lipid and Glucose Study. Hakim Health Sys Res 2016; 19(1): 25- 32 .

http://hakim.hbi.ir/browse.php?a_id=1662&sid=1&slc_lang=en

265. Noroozzadeh M, Ramezani Tehrani F, Zadeh-Vakili A, Piryaei A, Ghasemi A, Azizi F. The effects of testosterone intrauterine disturbance on sperm quality and testis tissue in male rat's offspring after puberty. Iran South Med J. 2016; 19 (3) :372-384.

http://ismj.bpums.ac.ir/article-1-801-en.html

266. Hakimi S, Nazarpour S, Ramezani Tehrani F, Simbar M, Zaiery F. Women's Experiences about Menopause and Related Factors. Iranian Journal of Endocrinology and Metabolism. 2017; 19 (3) :185-193.

http://ijem.sbmu.ac.ir/article-1-2250-en.html

267. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. Adverse Cardiometabolic Effect in Bilateral/Unilateral Oophorectomy Versus Natural Menopause: Results of Over a Decade Follow-up Among Iranian Women. Arch Iran Med. December 2017;20(12):734-739. (IF=1.2)

https://pubmed.ncbi.nlm.nih.gov/29664312/

268. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Quality of life and sexual function in postmenopausal women. J Women Aging. 2018 Jul-Aug;30(4):299-309 (IF= 0.658)

https://pubmed.ncbi.nlm.nih.gov/29077541/

269. Noroozzadeh M, Behboudi-Gandevani S, Zadeh-Vakili A, Tehrani FR. Hormone-induced rat model of polycystic ovary syndrome: A systematic review. Life Sci. 2017 Dec 15;191:259-272.

https://pubmed.ncbi.nlm.nih.gov/29055801/

270. Faghani Aghoozi M, Fayazi S, Tehranian N, Ramezani Tehrani F,  Salehin SH, Hamtama A,  Amerian M*. The Predictive Role of Serum Leptin Levels in Pregnant Mothers in Relation to their Delivery Type. Preventive Care in Nursing & Midwifery Journal. 2018; 8(1): 28-35.(SID)

http://zums.ac.ir/nmcjournal/browse.php?a_code=A-10-503-8&slc_lang=en&sid=1

271.  Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. Effects of Levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab. 2018 Mar 1;103(3):926-935. (IF=5.455)

https://pubmed.ncbi.nlm.nih.gov/29126290/

272. Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res. Int J Impot Res. 2018 Apr;30(2):54-61.  (IF=1.293)Q2

https://www.ncbi.nlm.nih.gov/pubmed/29242633

273. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017 Dec;108(6):1078-1084.

https://pubmed.ncbi.nlm.nih.gov/29202960/

274. Simbar M, Nazarpour S, Mirzababaie M, EmamHadi MA, Tehrani FR, Majd HA. Quality of Life and Body Image of Individuals with Gender Dysphoria. J Sex Marital Ther. 2018 Jan 3:0. doi: 10.1080/0092623X.2017.1419392. [Epub ahead of print].

https://www.ncbi.nlm.nih.gov/pubmed/29297758

275. Zeydabadi Nejad S, Ramezani Tehrani F, Zadeh-Vakili A. The Role of Kisspeptin in Female Reproduction. Int J Endocrinol Metab. 2017 Apr 22;15(3):e44337. (pubmed)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702467/

276. Hatami H, Montazeri SA, Hashemi N, Ramezani Tehrani F. Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome. Int J Endocrinol Metab. 2017 Jul 30;15(4):e12353. (pubmed)

https://pubmed.ncbi.nlm.nih.gov/29344030/

277. Nazarpour S, Ramezani Tehrani F, Simbar M, Minooee S, Rahmati M, Mansournia MA, Azizi F. Establishment of trimester-specific reference range for thyroid hormones during pregnancy. Clin Biochem. 2018 Mar;53:49-54

https://pubmed.ncbi.nlm.nih.gov/29337034/

278. A Mansournia M, Minooee S, Ramezani Tehrani F, Rahmati M, Azizi F. Authors' reply. Climacteric. 2018 Apr;21(2):196.

https://www.tandfonline.com/doi/abs/10.1080/13697137.2018.1441824

279. Amiri M, Kabir A, Nahidi F, Shekofteh M, Ramezani Tehrani F. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2018 Feb 192018 Feb 19, 23(1): 67-77. (IF=1.627)

https://pubmed.ncbi.nlm.nih.gov/29457756/

280. Salehi Jahromi M, Zadeh-Vakili A, Ramezani Tehrani F. The consequences of prenatal excess androgen exposure in anatomy of the reproductive system and physiology. Iranian journal of Endocrinology and Metabolism. December-January 2018; 19(5); 357-369. (scopus)

https://pdfs.semanticscholar.org/1a4a/ef856220e2dc1f8eb46883b207ddabf17214.pdf

281. Hajizadeh Sh , Ramezani Tehrani  F, Simbar M , Farzadfar  F. Effects of recruiting midwives into family physician program on the per-centage of low birth weight (LBW) infants in rural areas of Kurdistan. Med J Islam Repub Iran.  Dec 2017; 31(1): 1-8. (pubmed)

https://www.ncbi.nlm.nih.gov/pubmed/?term=Effects+of+recruiting+midwives+into+family+physician+program+on+the+per-centage+of+low+birth+weight+(LBW)+infants+in+rural+areas+of+Kurdistan

282. Minooee S, Ramezani Tehrani F. Rahmati, M., Mansournia M.A, Azizi, F. Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric. Jan 2018; 21(1): 29-34. (IF=2.271)

https://pubmed.ncbi.nlm.nih.gov/29106305/

283. Amiri M, Nahidi F, Khalili D, Bidhendi-Yarandi R, Ramezani Tehrani F. Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Res Protoc. 2017 Sep; 6(9): e191.

https://pubmed.ncbi.nlm.nih.gov/28963092/

284. Sareh Z, Azita Zadeh V, Mahsa N, Razieh Bidhendi Y, Asghar G, Amir RA, Ramezani Tehrani F. Prenatal Exposure of Kisspeptin Antagonist on the GonadotropinReleasing Hormone (GnRH) Expression in Rat Model of Polycystic Ovary Syndrome. J Fertil In Vitro IVF Worldw Reprod Med Genet Stem Cell Biol. 2017;  5(3): 1-8

https://www.longdom.org/open-access/prenatal-exposure-of-kisspeptin-antagonist-on-the-gonadotropinreleasinghormone-gnrh-expression-in-rat-model-of-polycystic-ovarysyn-2375-4508-1000206.pdf

285. Moslehi N, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis. Menopause. 2018 Sep;25(9):1046-1055.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Is+ovarian+reserve+associated+with+body+mass+index+and+obesity+in+reproductive+aged+women%3F+A+meta-analysis

286. Hatami H, Parizadeh D, Bidhendi Yarandi R, Tohidi M, Ramezani Tehrani F. Endogenous testosterone does not improve prediction of incident cardiovascular disease in a community-based cohort of adult men: results from the Tehran Lipid and Glucose Study. Aging Male. 2018 Apr 27:1-8. doi: 10.1080/13685538.2018.1466876.

https://pubmed.ncbi.nlm.nih.gov/29703118/

287. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F. Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. JMIR Res Protoc. 2018 Apr 25;7(4):e113.

https://pubmed.ncbi.nlm.nih.gov/29695378/

288. Nazarpour S, Simbar M, Tehrani FR, Majd HA. The relationship between menopausal symptoms and sexual function. Women Health. 19 Jan 2018 ; 58(10): 1112-1123

https://pubmed.ncbi.nlm.nih.gov/29240550/

289. Jahromi MS, Hill JW, Tehrani FR, Zadeh-Vakili A. Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats. Life Sci. 2018 May 30. pii: S0024-3205(18)30320-5. doi: 10.1016/j.lfs.2018.05.052. https://www.ncbi.nlm.nih.gov/pubmed/?term=Hypomethylation+of+specific+CpG+sites+in+the+promoter+region+of+steroidogeneic+genes+(GATA6+and+StAR)+in+prenatally+androgenized+rats

290. Rostami M, Ramezani Tehrani F, Simbar M, Bidhendi Yarandi R, Minooee S, Hollis BW, Hosseinpanah F. Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2936-2948.

https://pubmed.ncbi.nlm.nih.gov/29788364/

291. Sajadi M, Noroozzadeh M, Bagheripour F, Ramezani Tehrani F. Contractions in the Isolated Uterus of a Rat Model of Polycystic Ovary Syndrome Compared to Controls in Adulthood. Int J Endocrinol Metab. 2018 Apr 18;16(2):e63135.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035367/

292. Nasiri-Amiri F, Ramezani Tehrani F, Simbar M, Montazeri A, Mohammadpour RA. The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis. Int J Endocrinol Metab. 2018 Feb 3;16(2):e12400. (pubmed) Q3

https://www.ncbi.nlm.nih.gov/pubmed/30008755

293. Nazarpour S, Simbar M, Majd HA, Tehrani FR. Beneficial effects of pelvic floor muscle exercises on sexual function among postmenopausal women: a randomised clinical trial. Sex Health. 2018 Nov;15(5):396-402.

https://pubmed.ncbi.nlm.nih.gov/30048604/

294. Salehi Jahromi M, Hill JW, Ramezani Tehrani F, Zadeh-Vakili A. Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats. Life Sci. 2018 Aug 15;207:105-109.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Hypomethylation+of+specific+CpG+sites+in+the+promoter+region+of+steroidogeneic+genes+(GATA6+and+StAR)+in+prenatally+androgenized+rats

295. Moslehi N, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P, Azizi F. Systematic Review of the Association between BMI and Antimullerian Hormone (AMH) Levels in Reproductive Aged Women.. Iranian Journal of Endocrinology and Metabolism. June-july 2018; 20(2): 89-101.

http://ijem.sbmu.ac.ir/browse.php?a_id=2395&sid=1&slc_lang=en

296. Depmann M, Eijkemans MJC, Broer SL, Tehrani FR, Solaymani-Dodaran M, Azizi F, Lambalk CB, Randolph JF Jr, Harlow SD, Freeman EW, Sammel MD, Verschuren WMM, van der Schouw YT, Mol BW, Broekmans FJM. Does AMH relate to timing of menopause? Results of an Individual Patient Data meta- analysis. J Clin Endocrinol Metab. 2018 Jul 18. doi: 10.1210/jc.2018-00724. https://www.ncbi.nlm.nih.gov/pubmed/?term=Does+AMH+relate+to+timing+of+menopause%3F+Results+of+an+Individual+Patient+Data+meta-+analysis

297. Nazarpour S, Ramezani Tehrani F, Rahmati M, Minooee S, Simbar M, Noroozzadeh M, Azizi F. Validation of Billewicz Scoring System for Detection of Overt Hypothyroidism During Pregnancy. Int J Endocrinol Metab. 2018 Jul 7;16(3):e64249.

https://pubmed.ncbi.nlm.nih.gov/30323849/

298. Nazarpour S, Ramezani Tehrani F, Simbar M, Rahmati M, Azizi F. Frequency of positive thyroid peroxidase antibody and its related factors during pregnancy in pregnant women referring to the centers under coverage of Shahid Beheshti University of Medical Sciences 2013-2016. IJOGI. Sep 2018;  21(7): 20-28.

http://eprints.mums.ac.ir/10558/

299. Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. 2018 Dec;110(7):1377-1386.

https://pubmed.ncbi.nlm.nih.gov/30503137/

300. Ramezani Tehrani F, Behboudi-Gandevani S, Rostami Dovom M, Farahmand M, Minooee S, Noroozzadeh M, Amiri M, Nazarpour S, Azizi F. Reproductive Assessment: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018 Oct 20;16(4 Suppl):e84786.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289318/

301. Ramezani Tehrani F, Minooee S, Rostami M, Bidhendi Yarandi R, Hosseinpanah F. Response to Letter to the Editor (Effectiveness of Prenatal Vitamin D Deficiency Screening and Treatment Program: A Stratified Randomized Field Trial). J Clin Endocrinol Metab. 2019 Feb 1;104(2):339-340. https://pubmed.ncbi.nlm.nih.gov/30202978/

302. Amiri M, Bidhendi Yarandi R, Nahidi F, Tohidi M, Ramezani Tehrani F. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2019 Jan;90(1):129-137.

https://pubmed.ncbi.nlm.nih.gov/30229992/

303. Amiri M, Behboudi-Gandevani S, Minooee S, Ramezani Tehrani F. Age at Menopause in Women with Polycystic Ovary Syndrome: A Systematic Review. Iranian Journal of Endocrinology and Metabolism. 5 December-January 2019; 20(5): 274-286.

http://ijem.sbmu.ac.ir/browse.php?a_id=2460&slc_lang=en&sid=1&printcase=1&hbnr=1&hmb=1

304. Tehranian N, Hosseini M, Ramezani-Tehrani F, Yousefi S. Association of serum ghrelin with weight gain during pregnancy in overweight and normal women. J Endocrinol Invest. 2019 Jul;42(7):809-813.

https://www.ncbi.nlm.nih.gov/pubmed/30465249

305. Amiri M, Tehrani FR, Bidhendi-Yarandi R, Behboudi-Gandevani S, Azizi F, Carmina E. Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Horm Metab Res. 2019 Jan;51(1):22-34.

https://pubmed.ncbi.nlm.nih.gov/30650457/

306. Razavinia F, Tatari F, Bidhendi Yarandi R, Tehranian N, Ramezani Tehrani F. The postpartum marital satisfaction, maternal serum concentration of orexin-A and mode of delivery. J Sex Marital Ther. 2019;45(6):488-496.

https://pubmed.ncbi.nlm.nih.gov/30640582/

307.  Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Ramezani Tehrani F. The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome. 2019; 11:11. https://pubmed.ncbi.nlm.nih.gov/30733833/

308. Behboudi-Gandevani S, Ramezani Tehrani F, Rahmati M, Amiri M, Azizi F. trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study. BMC Endocrine Disorders. Feb 2019; 19:24.

https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-019-0348-5

309. Maryam F, Tehrani FR, Khalili D, Cheraghi L, Khomami MB, Azizi F. Association between duration of endogenous estrogen exposure and cardiovascular outcomes: A population - based cohort study. Life Sci. 2019 Mar 15;221:335-340.

https://pubmed.ncbi.nlm.nih.gov/30763578/

310. Nazarpour S, Ramezani Tehrani F, Sajedi F, Bidhendi Yarandi R, Azizi F. Evaluation of the impact of levothyroxine treatment on the psychomotor developmental status of three-year-old children born to mothers with mild thyroid impairment; Tehran Thyroid and pregnancy study: study protocol for a randomized clinical trial. Trials. 2019 Jan 28;20(1):86.

https://pubmed.ncbi.nlm.nih.gov/30691519/

311. Behboudi-Gandevani S, Ramezani Tehrani F, Rahmati M, Amiri M, Azizi F. Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study. BMC Endocr Disord. 2019 Feb 19;19(1):24.

https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-019-0348-5

312. Ramezani Tehrani F, Bidhendi Yarandi R. Improving the effectiveness of lifestyle interventions for gestational diabetes prevention: a meta-analysis and meta-regression. BJOG. 2019 Apr 1. doi: 10.1111/1471-0528.15674. https://pubmed.ncbi.nlm.nih.gov/30216635/

313. Montazeri SA, Ramezani Tehrani F, Bidhendi Yarandi R, Erfani H, Mansournia MA, Azizi F. Effect of aging, menopause, and age at natural menopause on the trend in body mass index: a 15-year population-based cohort. Fertil Steril. 2019 Apr;111(4):780-786.

https://pubmed.ncbi.nlm.nih.gov/30929733/

314. Sahraeian M, Lotfi R, Qorbani M, Faramarzi M, Dinpajooh F, Tehrani FR. The Effect of Cognitive Behavioral Therapy on Sexual Function in Infertile Women: A Randomized Controlled Clinical Trial. J Sex Marital Ther. 2019 Mar 26:1-14. doi: 10.1080/0092623X.2019.1594476.

https://www.ncbi.nlm.nih.gov/pubmed/30912475

315. Ramezani-Tehrani F, Rahmani K, Moradi A, Montazeri SA, Bidhendi-Yarandi R, Darabi F. Comparison of Two Statistical Methods to Determine Normal Range of Androgen Hormones: K-Means Cluster Analysis and Receiver Operating Characteristic Curve. J Family Reprod Health. 2018 Jun;12(2):96-102. (Pubmed) Q3

https://pubmed.ncbi.nlm.nih.gov/30820213/

316. Rostami Dovom M, Moslehi N, Mirmiran P, Azizi F, Ramezani Tehrani F. Habitual dietary lactose and galactose intakes in association with age at menopause in non-galactosemic women. PLoS One. 2019 Mar 19;14(3):e0214067. (ISI 2.766) Q1

https://pubmed.ncbi.nlm.nih.gov/30889195/

317. Noroozzadeh M, Behboudi-Gandevani S, Mosaffa N, Tohidi M, Ramezani Tehrani F. High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period. Gynecol Endocrinol. 2019 Aug;35(8):679-684.

https://pubmed.ncbi.nlm.nih.gov/30990105/

318. Bahri S, Tehrani FR, Amouzgar A, Rahmati M, Tohidi M, Vasheghani M, Azizi F. Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12-year follow up. BMC Endocr Disord. 2019 May 7;19(1):47.

https://www.ncbi.nlm.nih.gov/pubmed/31064360

319. Danaei G, Farzadfar F, Kelishadi R, Rashidian A, Rouhani OM, Ahmadnia S, Ahmadvand A, Arabi M, Ardalan A, Arhami M, Azizi MH, Bahadori M, Baumgartner J, Beheshtian A, Djalalinia S, Doshmangir L, Haghdoost AA, Haghshenas R, Hosseinpoor AR, Islami F, Kamangar F, Khalili D, Madani K, Masoumi-Asl H, Mazyaki A, Mirchi A, Moradi E, Nayernouri T, Niemeier D, Omidvari AH, Peykari N, Pishgar F, Qorbani M, Rahimi K, Rahimi-Movaghar A, Tehrani FR, Rezaei N, Shahraz S, Takian A, Tootee A, Ezzati M, Jamshidi HR, Larijani B, Majdzadeh R, Malekzadeh R. Iran in transition. Lancet. 2019 Apr 26. pii: S0140-6736(18)33197-0.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)33197-0/fulltext

320. Golezar, S., Ramezani Tehrani, F., Khazaei, S., Ebadi, A., Keshavarz, Z. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019 Aug;22(4):403-411

https://www.tandfonline.com/doi/abs/10.1080/13697137.2019.1574738?journalCode=icmt20

321. Faghani Aghoozi M, Fazaei S, Amerian M, Hamta A, Tehranian N, Ramezani Tehrni F. Investigation of the Relationship between Serum Leptin levels and Nausea and Vomiting of Pregnancy. Preventive Care in Nursing & Midwifery Journal. 2018; 7(4): 64-71.

http://zums.ac.ir/nmcjournal/article-1-564-en.html

322. Amiri M, Ramezani Tehrani F, Rahmati M, Behboudi-Gandevani S, Azizi F. Changes over-time in blood pressure of women with preeclampsia compared to those with normotensive pregnancies: A 15 year population-based cohort study. Pregnancy Hypertension. July 2019; 17: 94-99. https://www.sciencedirect.com/science/article/abs/pii/S2210778918307098

323. Noroozzadeh M, Raoufy MR, Bidhendi Yarandi R, Faraji Shahrivar F, Ramezani Tehrani F. The effects of prenatal androgen exposure on cardiac function and tolerance to ischemia/reperfusion injury in male and female rats during adulthood. Life Sci. 2019 Jul 15;229:251-260.

https://pubmed.ncbi.nlm.nih.gov/31112711/

324. Minooee S, Ramezani Tehrani F, Rahmati M, Amanollahi Soudmand S, Tohidi M, Sabet Z, Azizi F. The association between serum total testosterone and progression of hyperglycemia: a 15-year prospective cohort study. Andrology. 2019 Mar;7(2):148-155.

https://pubmed.ncbi.nlm.nih.gov/30666808/

325. Mokhlesi S, Simbar M, Ramezani Tehrani F, Kariman N, Alavi Majd H. Quality of Life and Gestational Diabetes Mellitus: A Review Study Review Study. International Journal of Women’s Health and Reproduction Sciences. July 2019; 7(3): 255-262.

http://www.ijwhr.net/pdf/pdf_IJWHR_403.pdf

326. Bidhendi Yarandi R, Behboudi-Gandevani S, Amiri M, Ramezani Tehrani F. Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression. Diabetol Metab Syndr. 2019 Jul 23;11:58. doi: 10.1186/s13098-019-0453-7. eCollection 2019.

https://pubmed.ncbi.nlm.nih.gov/31367235/

327. Behboudi-Gandevani S, Abtahi H, Saadat N, Tohidi M, Ramezani Tehrani F Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial. J Ovarian Res. 2019 Aug 30;12(1):78. https://pubmed.ncbi.nlm.nih.gov/31470879/

328. Golezar S, Ramezani-Tehrani F, Ebadi A, Keshavarz Z, Zayeri F. Coping with Primary Ovarian Insufficiency in Iranian Women: A Qualitative Study. J Isfahan Med Sch 2019; 37(529): 608-16.

https://www.magiran.com/paper/2020425

329. Farahmand M, Ramezani Tehrani F, Behboudi Gandevani S, Azizi F. Is There any Association between Age at Menarche and Risk of Metabolic Syndrome? The Tehran Lipid & Glucose Study. Arch Iran Med. 2019 Sep 1;22(9):495-500

https://pubmed.ncbi.nlm.nih.gov/31679370/

330. Nazarpour S, Ramezani Tehrani F,  Azizi F. The effects of levothyroxine treatment in mothers with thyroid dysfunction on children's neurocognitive development: systematic review.  The Iranian Journal of Obstetrics, Gynaecology and Infertility; Oct 2019; 22(8): 62-73.

http://ijogi.mums.ac.ir/article_13921.html

331. Nazarpour S, Ramezani Tehrani F, Amiri M, Bidhendi Yarandi R, Azizi F. Levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis. Arch Gynecol Obstet. 2019 Oct;300(4):805-819

https://pubmed.ncbi.nlm.nih.gov/31399840/

332. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Medical conditions and sexual dysfunction in post-menopausal women. Sexual and Relationship Therapy. 01 Oct 2019.

https://www.tandfonline.com/doi/abs/10.1080/14681994.2019.1672866?journalCode=csmt20

333. Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, Ghasemi V. The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis. Int J Reprod Biomed (Yazd). 2019 Sep 3;17(8):533-542.  (ISI , Q2)

https://pubmed.ncbi.nlm.nih.gov/31583370/

334. Shishehgar F, Mirmiran P, Rahmati M, Tohidi M, Ramezani Tehrani F. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome? BMC Endocr Disord. 2019 Sep 2;19(1):93.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720418/

335. Nazarpour S, Simbar M, RamezaniTehrani F. Sexual Function in Postmenopausal Women and Serum Androgens: A Review Article. International Journal of Sexual Health. 2019; 31(3):244-256.

https://www.tandfonline.com/doi/abs/10.1080/19317611.2019.1622617?journalCode=wijs20

336. Rostami Dovom M, Noroozzadeh M, Mosaffa N, Zadeh-Vakili A, Piryaei A, Ramezani Tehrani F. Induced premature ovarian insufficiency by using D galactose and its effects on reproductive profiles in small laboratory animals: a systematic review. J Ovarian Res. 2019 Oct 16;12(1):96.

https://pubmed.ncbi.nlm.nih.gov/31619267/

337. Saei Ghare Naz M, Ramezani Tehrani F, Ahmadi F, Alavi Majd H, Ozgoli G. Threats to feminine identity as the main concern of Iranian adolescents with polycystic ovary syndrome: A qualitative study. J Pediatr Nurs. 2019 Nov - Dec;49:e42-e47.

https://pubmed.ncbi.nlm.nih.gov/31645273/

338. Ramezani Tehrani F and Gulf Study Cooperative Research Group. Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial. Diabetology & Metabolic Syndrome. 2019, 11(106) (2019).

https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-019-0493-z

339. Moslehi N, Mirmiran P, Azizi F, Tehrani FR. Do dietary intakes influence the rate of decline in anti-Mullerian hormone among eumenorrheic women? A population-based prospective investigation. Nutr J. 2019 Dec 2;18(1):83. https://pubmed.ncbi.nlm.nih.gov/31791350/

340. Erfani H, Rahmati M, Mansournia MA, Azizi F, Montazeri SA, Shamshirsaz AA, Ramezani Tehrani F. Association between ovarian reserve and preeclampsia: a cohort study. BMC Pregnancy Childbirth. 2019 Nov 21;19(1):432. https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-019-2578-y

341. Amiri M, Ramezani Tehrani F, Rahmati M, Amanollahi Soudmand S, Behboudi-Gandevani S, Sabet Z, Azizi F. Low serum testosterone levels and the incidence of chronic kidney disease among male adults: A prospective population based study. Andrology. 2019 Nov 7. doi: 10.1111/andr.12728.

https://pubmed.ncbi.nlm.nih.gov/31697870/

342. Saei Ghare Naz M, Ramezani Tehrani F, Ozgoli G. Polycystic Ovary Syndrome in adolescents: a qualitative study. Psychol Res Behav Manag. 2019 Aug 22;12:715-723. https://www.dovepress.com/polycystic-ovary-syndrome-in-adolescents-a-qualitative-study-peer-reviewed-article-PRBM

343. Mokhlesi S, Simbar M, Ramezani Tehrani F, Kariman N, Alavi Majd H. Quality of life questionnaire for women with gestational diabetes mellitus (GDMQ-36): development and psychometric properties. BMC Pregnancy Childbirth. 2019 Nov 29;19(1):454.

https://pubmed.ncbi.nlm.nih.gov/31783733/

344. mokhlesi S, simbar M, ramezani tehrani F, kariman N, alavi H. Perceived Concerns and Constraints of Mothers with Gestational Diabetes: A Qualitative Study. Iranian Journal of Endocrinology and Metabolism. 2019; 20 (6) :356-366. (Scopus)

http://ijem.sbmu.ac.ir/article-1-2481-en.html

345. Ramezani Tehrani F,  Amiri M. Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment. Int J Endocrinol Metab. 2019 Jul; 17(3): e91554. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679603/

346. Amiri M, Nahidi F, Bidhendi-Yarandi R, Khalili D, Tohidi M, Ramezani Tehrani F. A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial. Hum Reprod. 2020 Jan 9. pii: dez255. doi: 10.1093/humrep/dez255..

347. Bidhendi Yarandi R, Rostami-Dovom M, Mohammad K, Ramezani Tehrani F To the Editor. Menopause. 2020 Feb;27(2):249. https://pubmed.ncbi.nlm.nih.gov/31895177/

348. Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020 Mar 17;18(1):23.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076940/

349. Saei Ghare Naz M, Ramezani Tehrani F, Behroozi Lak T, Mohammadzadeh F, Nasiri M, Kholosi Badr F, Ozgoli G. Quality of Life and Emotional States of Depression, Anxiety and Stress in Adolescents with Polycystic Ovary Syndrome: A Cross-Sectional Study. Psychol Res Behav Manag. 2020 Feb 28; 13:203-209. (IF=2.02, Q2)

https://www.dovepress.com/quality-of-life-and-emotional-states-of-depression-anxiety-and-stress--peer-reviewed-article-PRBM

350. Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Azizi F. Is there any association between age at menarche and anthropometric indices? A 15-year follow-up population-based cohort study. Eur J Pediatr. 2020 Sep;179(9):1379-1388.

https://pubmed.ncbi.nlm.nih.gov/32146570/

351. Ramezani Tehrani F, Bidhendi Yarandi R, Solaymani-Dodaran M, Tohidi M, Firouzi F, Azizi F. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: the Tehran Lipid-Glucose Study. J Clin Endocrinol Metab. 2020 May 1;105(5). pii: dgaa083.

https://pubmed.ncbi.nlm.nih.gov/32109280/

352. Panahi MH, Mohseni M, Bidhendi Yarandi R, Ramezani Tehrani F. A methodological quality assessment of systematic reviews and meta-analyses of antidepressants effect on low back pain using updated AMSTAR. BMC Med Res Methodol. 2020 Jan 23;20(1):14.  

https://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-0903-9

353. Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2020 Jan;36(1):12-23.

https://pubmed.ncbi.nlm.nih.gov/31385729/

354. Behboudi-Gandevani S, Modoodi M, Bidhendi Yarandi R, Amiri M, Momenan A A, Azizi, Ramezani Tehrani F*. Relationship between history of gestational diabetes and the risk of breast cancer: a population based cohort study. ijdld. 2019; 19 (1) :36-43
     http://ijdld.tums.ac.ir/article-1-5893-fa.html

355. Nazarpour S, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi Yarandi R, Azizi F.Maternal Urinary Iodine Concentration and Pregnancy Outcomes in Euthyroid Pregnant Women. Biol Trace Elem Res. 2019 Dec 24. doi: 10.1007/s12011-019-02020-x.

https://pubmed.ncbi.nlm.nih.gov/31873919/

356. Amiri M, Ramezani Tehrani F, Rahmati M, Firouzi F, Azizi F. Do trends of adiposity and metabolic parameters vary in women with different ovarian reserve status? A population-based cohort study. Menopause. 2020 Jun;27(6):684-692.

https://pubmed.ncbi.nlm.nih.gov/32301892/

357. Hoorsan H, Simbar M, Ramezani Tehrani F, Fathi F, Mosaffa N, Riazi H. induction of the mice model regarding the endometriosis and assessment of antioxidant treatment effectiveness: An experimental protocol. international journal of women's health and reproduction sciences. April 2020; 8(2): 133-141.

http://www.ijwhr.net/pdf/pdf_IJWHR_506.pdf

358. Hatami H, Montazeri SA*, Hashemi N, Ramezani Tehrani F. Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome. Int J Endocrinol Metab. 2017 Jul 30;15(4):e12353.

https://www.ncbi.nlm.nih.gov/pubmed/?term=Optimal+Cutoff+Points+for+Anthropometric+Variables+to+Predict+Insulin+Resistance+in+Polycystic+Ovary+Syndrome

359. Behboudi-Gandevani S, Amiri M, Rahmati M, Amanollahi Soudmand S, Azizi F, Ramezani Tehrani F. Preeclampsia and the Ten-Year Risk of Incident Chronic Kidney Disease. Cardiorenal Med. 2020 Apr 16: 10(3): 188-197. https://pubmed.ncbi.nlm.nih.gov/32299082/

360. Saei Ghare Naz M, Amiri M, Ramezani Tehrani F. The Evolutionary Approach for Diagnostic Criteria of Polycystic Ovary Syndrome in Adolescents: a Review. Iranian Journal of Endocrinology and Metabolism. 2019; 21 (4) :253-265. http://ijem.sbmu.ac.ir/article-1-2624-fa.html

361.  Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Mahd H. The Relationship between Sexual Function and Body Mass Index in Postmenopausal Women. Acta scientific women’s health. Feb 2020. 2(3); 1-5.

https://www.researchgate.net/publication/339716301_The_Relationship_between_Sexual_Function_and_Body_Mass_Index_in_Postmenopausal_Women

362. Saei Ghare Naz M, Ramezani Tehrani F, Behroozi-Lak T, Mohammadzadeh F, Kholosi Badr F, Ozgoli G. Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review. 7 may 2020. 2020:12: 179-185.

https://www.dovepress.com/polycystic-ovary-syndrome-and-pelvic-floor-dysfunction-a-narrative-rev-peer-reviewed-article-RRU

363. Nazarpour S, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi Yarandi R, Azizi F. Maternal Urinary Iodine Concentration and Pregnancy Outcomes in Euthyroid Pregnant Women: a Systematic Review and Meta-analysis. Biol Trace Elem Res. Biol Trace Elem Res. 2020 Oct;197(2):411-420. . (IF=2.639, Q2)

https://pubmed.ncbi.nlm.nih.gov/31873919/

364. Noroozzadeh M, Sarahian N, Bidhendi Yarandi R, Ramezani Tehrani F. Evaluation of Cardiac Hemodynamic Parameters Following Ischemia-Reperfusion Injury in a Rat Model of Polycystic Ovary Syndrome. Journal of Mazandaran University of Medical Sciences. May 2020; 30(184): 73-85.

http://jmums.mazums.ac.ir/article-1-14608-fa.pdf

365. Nazarpour S, Simbar M, Ramezani Tehrani F, Alavi Majd H. Factors associated with quality of life of postmenopausal women living in Iran. BMC women’s helath. 2020: 20:104.

https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-020-00960-4

366. Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, Majd HA, Nahidi F*. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Disord. 2020 May 19;20(1):71. (IF=1.994, Q2)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236342/pdf/12902_2020_Article_552.pdf

367. Rostami Dovom M, Ramezani Tehrani F. A Review of the Relationship between Obesity and Some Sexual Dysfunction in Men and Women. Iranian Journal of Endocrinology and Metabolism. 2020; 21 (5) :319-328
     http://ijem.sbmu.ac.ir/article-1-2669-fa.html

368. Rostami Dovom M, Behboudi Gandavani S, Farahmand M, Nazarpoor S, Ramezani Tehrani F, Azizi F.  Comparison of maternal and fetal complications in women with various phenotypes of Polycystic Ovary Syndrome.The Iranian journal of obstetrics, gynaecology and infertility. May 2020; 23(3): 58-67.

http://ijogi.mums.ac.ir/article_15998.html

369. Saei Ghare Naz M, Ramezani Tehrani F,Behrozi-Lak T,  Koohi F, Dalil Heirati SF, Abed M, Ozgoli G*. The level of Prostate specific antigen (PSA) in patients with polycystic ovarian syndrome: Systematic review and Meta-analysis. The Iranian journal of obstetrics, gynaecology and infertility. Apr-May 2020. 23(2): 102-111.

http://eprints.mums.ac.ir/19448/

370. Meyari A, Ramezani Tehrani F, Tansaz M, mokaberinejad R, Biglarkhani M*. Wet Cupping and Phlebotomy in Management of Oligo/Amenorrhea: View of Persian Medicine. Tranditional and integrative medicine. Spring 2020, 5(2). (SCOPUS) 

https://jtim.tums.ac.ir/index.php/jtim/article/view/216

371. Behboudi-Gandevani S, Amiri M, Cheraghi L, Amanollahi Soudmand S, Azizi F, Ramezani Tehrani F*. The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study. Clin Endocrinol (Oxf). 2020 Jul 12. doi: 10.1111/cen.14284. [Epub ahead of print]. (IF=3.380, Q1)

https://onlinelibrary.wiley.com/doi/epdf/10.1111/cen.14284

372. Eftekharzadeh S,  Ebrahimi  N,  Samaei M,  Mohebi  F,  Mohajer B,  Sheidaei  A ,  Gohari K,  Saeedi Moghaddam  S ,  Ahmadi  N ,  Mohammadi Fateh S,  Ramezani Tehrani F,  Farzadfar F*. National and Subnational Trends of Incidence and Mortality of Female Genital Cancers in Iran; 1990-2016 Arch Iran Med.. 2020 Jul 1;23(7):434-444. (IF=0.996, Q2)

http://www.aimjournal.ir/Article/aim-13729

373. Panahi MH, Mohammad K, Bidhendi Yarandi R, Ramezani Tehrani F. Dealing With Sparse Data Bias in Medical Sciences: Comprehensive Review of

Methods and Applications. acta medica iranica. 2020. 58(11): 591-598. (SCOPUS, Q2)

https://acta.tums.ac.ir/index.php/acta/article/view/8564

374. Keshavarzi B, Tabatabaei M,  Zarnani A,  Ramezani Tehrani F,  Bozorgmehr M, Mosaffa N*. The effect of human amniotic epithelial cell on dendritic cell differentiation of peripheral blood monocytes: An experimental study. International Journal of Reproductive Biomedicine. 2020, 18(6): 449-464. (ISI(ESCI), pubmed, Q2)

http://journals.ssu.ac.ir/ijrmnew/article-1-1077-en.html

376- , 000 ریال بابت ورود اطلاعات طرح سی پپتید، 617 مورد سالم،  مصرفی موافقت بعمل آمد:

375. Golezar S, Keshavarz Z*, Ramezani Tehrani F,Ebadi A. An exploration of factors affecting the quality of life of women with primary ovarian insufficiency: a qualitative study. BMC women's health. 5 Aug 2020; 20(1): 163. (IF=1.554, Q3)

https://bmcwomenshealth.biomedcentral.com/track/pdf/10.1186/s12905-020-01029-y

376. Tehrani, F.R.Hashemi, N*.Montazeri, S.A.,Rahmati, M, Hatami, H. Optimal reference values for insulin sensitivity indices in Iranian healthy females: a population-based study. International Journal of Diabetes in Developing Countries. 2020, article in press. (IF=0.525, Q3)

https://www.scopus.com/record/display.uri?eid=2-s2.0-85084047034&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=f9702ec574881916b6e6badd833a3048&sot=aff&sdt=cl&cluster=scopubyr%2c%222020%22%2ct&sl=60&s=AF-ID%28%22Reproductive+Endocrinology+Research+Center%22+60109330%29&relpos=22&citeCnt=0&searchTerm=

377. Bidhendi Yarandi R, Mohammad K, Zeraati H, Ramezani Tehrani F, Mansournia M A*. Bayesian methods for clinicians. Med J Islam Repub Iran. 2020; 34 (1) :548-553. (pubmed, Q2)
     http://mjiri.iums.ac.ir/article-1-6079-en.html

378. Noroozzadeh M, Raoufy MR, Yarandi RB, Shahrivar FF, Moghimi N, Tehrani FR*. Cardiac function and tolerance to ischemia/reperfusion injury in a rat model of polycystic ovary syndrome during the postmenopausal period. Life Sci. 1 December 2020.262: 118394. (IF=3.647, Q1)

https://www.sciencedirect.com/science/article/abs/pii/S0024320520311474

379. Amiri M, Bidhendi-Yarandi R, Nahidi F, Ramezani Tehrani F. Effects of Etisterone and Contrasmine pills on clinical and biochemical findings of hyperandrogenism and metabolic parameters of patients with polycystic ovary syndrome: A randomized clinical trial. The Iranian Journal of Obstetrics, Gynecology and Infertility. Aug 2020; 23(6): 29-42. (Scopus)

http://ijogi.mums.ac.ir/article_16877.html

380. Amiri M, Nahidi F, Yarandi RB, Khalili D, Tohidi M, Tehrani FR. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health Qual Life Outcomes. 2020 Aug 31;18(1):293.(IF=2.344, Q1)

https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32867790

381. Saei Ghare Naz M, Ramezani Tehrani F. Turning the threat of SARS-CoV-2 crisis into an opportunity for a better lifestyle in adolescents with polycystic ovary syndrome.  J Pediatr Nurs. 2020 Sep 3;S0882-5963(20)30590-X. (IF=1.495, Q1)

https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32972806

382. Zahedi M, Kazemian E, Ramezani-Tehrani F*, Tohidi M, Azizi F,  Khalili D, Rahmati M, Amouzegar A*. Assessment of the simultaneous effect of hypothyroidism and thyroid autoimmunity with gestational diabetes on the incidence of type 2 diabetes. BMC Endocr Disord. 2020 Oct 1;20(1):150. (IF= 1.994, Q2)

https://pubmed.ncbi.nlm.nih.gov/32998711/

383. Saei Ghare Naz M, Ramezani Tehrani F*. SARS-CoV-2: Future potential impact on timing of menarche and onset of the regular menstrual cycle in adolescents. J Pediatr Nurs. 2020 Oct 16;S0882-5963(20)30622-9. (IF=1.495, Q1)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566796/

384. Saei Ghare Naz M, Rostami Dovom M, Ramezani Tehrani F*. The Menstrual Disturbances in Endocrine Disorders: A Narrative Review. Int J Endocrinol Metab. 14 Oct 2020. e106694. (Pubmed, Q3)

https://sites.kowsarpub.com/ijem/articles/106694.html

385. - Rostami M, Simbar M,  Amiri M, Bidhendi-Yarandi R, Hosseinpanah F,  Ramezani Tehrani F*. The optimal cut-off point of vitamin D for pregnancy outcomes using a generalized additive model. Clin Nutr. 2020 Oct 2;S0261-5614(20)30511-2. (IF=6.360, Q1)

https://www.sciencedirect.com/science/article/abs/pii/S0261561420305112?via%3Dihub

386. Mahboobifard, F., Dargahi, L., Jorjani, M., Ramezani Tehrani, F*. Pourgholami, M.H. The role of ERα36 in cell type-specific functions of estrogen and cancer development. Pharmacol Res. 2020 Nov 25;163:105307. (IF=5.893, Q1)

https://pubmed.ncbi.nlm.nih.gov/33246174/

387. Amiri M, Bidhendi-Yarandi R, Nahidi F, Ramezani Tehrani F*. Comparison of the Effects of Desoceptive and Etisterone Pills on the Clinical, Hormonal, and Metabolic Findings of Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial. Iranian Journal of Endocrinology and Metabolism. 2020; 22 (2) :137-150. (SCOPUS)

http://ijem.sbmu.ac.ir/browse.php?a_id=2724&sid=1&slc_lang=fa

388. Farahmand M. Khalili D. Ramezani Tehrani F, Amin GR, Negarandeh R*. Effectiveness of Echium amoenum on premenstrual syndrome: a randomized, double-blind, controlled trial. BMC Complement Med Ther.. 2020 Sep 29;20(1):295. (IF=2.833, Q1)

https://pubmed.ncbi.nlm.nih.gov/32993653/

389. Amiri, M., Bidhendi-Yarandi, R., Nahidi, F., Tehrani, F.R*. Effects of etisterone and contrasmine pills on clinical and biochemical findings of hyperandrogenism and metabolic parameters of patients with polycystic ovary syndrome: A randomized clinical trialIranian Journal of Obstetrics, Gynecology and Infertility, 2020, 26(6), pp. 29–42. (SCOPUS)

390. Ramezani Tehrani F, Nazarpour S*. Relationship between mode of delivery and neonatal thyroid hormone levels at birth: a narrative review. Nurs Midwifery J. 2020; 18 (8) :608-618.

http://unmf.umsu.ac.ir/article-1-4133-fa.html

391. Ramezani Tehrani F*,  Behboudi-Gandevani S, Bidhendi Yarand R,  Saei Ghare Naz M, Carmina E. Prevalence of acne vulgaris among women with polycystic ovary syndrome: a systemic review and meta-analysis. Gynecol Endocrinol. 2020 Dec 23;1-14. (IF=1.571, Q2)

https://pubmed.ncbi.nlm.nih.gov/33355023/

392. Amiri M, Ramezani Tehrani F*. Potential Adverse Effects of Female and Male Obesity on Fertility: A Narrative Review. Int J Endocrinol Metab. 2020 Sep 28;18(3):e101776. (Pubmed, Q3)

https://pubmed.ncbi.nlm.nih.gov/33257906/

393. Farahmand M, Khalili D, Ramezani Tehrani F, Amin G, Negarandeh R*. Could Anise decrease the intensity of premenstrual syndrome symptoms in comparison to placebo? A double-blind randomized clinical trial. J Complement Integr Med. 1 December 2021; 17(4): . (IF=pubmed, Q2)

https://pubmed.ncbi.nlm.nih.gov/32692701/

394. Ramezani Tehrani F, Nazarpour S*, Behboudi-Gandevani S. Isolated Maternal Hypothyroxinemia and adverse pregnancy outcomes: A systematic review. journal of gynecology obstetrics and human reproduction. Sep 2021, 50(7): 102057  (IF=1.233, Q3)

https://www.researchgate.net/publication/342789624_Isolated_Maternal_Hypothyroxinemia_and_Adverse_Pregnancy_Outcomes_A_Systematic_Review

395. Saei Ghare Naz M, Rostami Dovom M, Ramezani Tehrani F*. Modern pharmacological trearments of sexual dysfunction in women: a narrative review. The Iranian journal of obstetrics, gynecology and infertility. Nov 2020, 23(9): 69-84. (Scopus, Q)

https://ijogi.mums.ac.ir/article_17388.html

396.  Moazzeni SS,Toreyhi H, Asgari S, Azizi F, Ramezani Tehrani F, Hadaegh F*. Number of parity/live birth(s) and cardiovascular disease among Iranian women and men: results of over 15 years of follow-up. BMC pregnancy and childbirth. 07 jan 2021; 21(1):28. (IF=2.239, Q2)

https://pubmed.ncbi.nlm.nih.gov/33413159/

397. Saei Ghare Naz M,  Ramezani Tehrani F*. Effect of Laser and Intense Pulsed Light in treatment of hirsutism in women with polycystic ovary syndrome (PCOS): A systematic review. The Iranian Journal of Obstetrics, Gynecology and Infertility. Dec 2020. 23(10): 96-108. (Scopus, Q3)

https://ijogi.mums.ac.ir/article_17493.html?lang=en

398. Sarahian N, Noroozzadeh M, Changaei M, Ramezani Tehrani F*. The Role of Central Nervous System and Hypothalamic-Pituitary-Gonadal (HPG) Axis Changes in the Occurrence of Polycystic Ovary Syndrome: A Narrative Review Article. JRUMS. 2020; 19 (7) :727-748. (SID)

https://journal.rums.ac.ir/browse.php?a_id=5468&sid=1&slc_lang=fa&html=1

399. Farahmand M, Ramezani Tehrani F*, Azizi F. Comparison of the prevalence rates of metabolic disorders between two groups of women undergone surgically induced menopause by hysterectomy and bilateral oophorectomy: A population-based study. SJKU. 2021; 25 (6) :79-89. (Scopus, Q3)

http://sjku.muk.ac.ir/browse.php?a_code=A-10-4934-1&slc_lang=fa&sid=1

400. Nasiri S, Dolatian M*, Ramezani Tehrani F*, Alavi Majd H. Factors Related to the Age at Menarche in Iran: A Systematic Review and Meta-Analysis. International Journal of Pediatrics. January 2021; 8(9): 12091-12104. (ISI)

https://ijp.mums.ac.ir/article_15819_ee591e5677ffaa0214298b5a75ad030f.pdf

401. Ramezani Tehrani F,  Saei Ghare Naz M, Bidhendi Yarand R, Behboudi-Gandevani S*. The Impact of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Maternal Outcomes: A Systematic Review and Meta-Analysis. Journal of clinical medicine. 9 Feb 2021. 10(4): 666. (IF=3.303, Q1)

https://www.mdpi.com/2077-0383/10/4/666

402. Moslehi N, Mirmiran P, Marzbani R, Rezadoost H, Mirzaie M, Azizi F, Tehrani FR. Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography-mass spectrometry-based study. Hum Reprod. 2021 Feb 18;36(3):721-733. (IF=5.733, Q1)

https://academic.oup.com/humrep/article-abstract/36/3/721/6009000?redirectedFrom=fulltext

403. Rostami Dovom M, Bidhendi‑Yarandi R*, Mohammad K, Farahmand M, Azizi F, Ramezani Tehrani F. Prevalence of premature ovarian insufciency and its determinants in Iranian populations: Tehran lipid and glucose study. BMC Women's health. 23 Feb 2021; 21(1):79. (IF=1.544, Q2)

https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-021-01228-1

404. Amiri M, Ramezani Tehrani F*. Comparison of the Effects of Combined Oral Contraceptives Containing Progestins with Low Androgenic and Anti-androgenic Activities on the Clinical, Androgenic, and Metabolic Manifestations of Polycystic Ovary Syndrome. Iranian Journal of Endocrinology and Metabolism. 2020; 22 (1) :83-91. (scopus)

http://ijem.sbmu.ac.ir/article-1-2717-en.html

405. Suri, S., Dehghan, S.F., Sahlabadi, A.S. Ardakani S. K. Moradi N., Rahmati, M., Tehrani, F.R. Relationship between exposure to Extremely Low-Frequency (ELF) magnetic field and the level of some reproductive hormones among power plant workers. Journal of Occupational Health. January/December 2020; 62(1): e12173. (IF=2.289, Q2)

https://onlinelibrary.wiley.com/doi/full/10.1002/1348-9585.12173

406. Amiri M, Rahmati M, Hedayati M, Nahidi F, Ramezani F*. Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial. Journal of endocrinological investigation. . Mar 2021; 44(3): 567-580. (IF=3.397, Q2)

https://link.springer.com/article/10.1007/s40618-020-01349-8

407. Moslehi N, Mirmiran P, Marzbani R, Rezadoost H*, Mirzaie M, Azizi F, Ramezani Tehrani F*.  Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography-mass spectrometry-based study. Hum Reprod. 2021 Feb; 18; 36(3):721-733. (IF=5.733, Q1)

https://pubmed.ncbi.nlm.nih.gov/33320198/

408. Valizadeh M, Hosseinpanah F, *, Ramezani Tehrani F, Abdi H, **, Mehran L, Hadaegh F, Amouzegar A, Sarvghadi F, Azizi F.and  Iranian Endocrine Society Task Force. Iranian Endocrine Society Guidelines for Screening, Diagnosis, and Management of Gestational Diabetes Mellitus. Int J Endocrinol Metab. 2021 January; 19(1):e107906. (pubmed, Q3)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010429/

409. Saei Ghare Naz M, Ramezani Tehrani F^*. Effect of cinnamon on polycystic ovary syndrome (PCOS): A Systematic Review. The Iranian Journal of Obstetrics, Gynecology and Infertility. February 2021; 23(12): 86-97. (Scopus, Q3)

https://ijogi.mums.ac.ir/article_17831.html

410.  Sarahian N, Saei Ghare Naz M, Ramezani Tehrani F*. Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment? Endocrine. 2021 Mar 15;1-2. (IF=3.235, Q2, Letter)

 https://pubmed.ncbi.nlm.nih.gov/33721205/

411. Behboudi-Gandevani S,  Bidhendi Yarandi R,  Rostami Dovom M,  Azizi F,  Ramezani Tehrani F*. The Association Between Male Infertility and Cardiometabolic Disturbances: A Population-Based Study International Journal of Endocrinology and Metabolism: April 13, 2021 19 (2); e107418. (pubmed, Q3, research article)

https://sites.kowsarpub.com/ijem/articles/107418.html

412. Mohammadi H, Golbabaei F*, Farhang Dehghan S, Khodakarim Ardakani S, Imani H, Ramezani Tehrani F. Effect of occupational exposure to whole-body vibration and noise on Sex Hormone Levels: A Case Study in an Automobile Parts Manufacturing Plant. ………………….

https://www.researchsquare.com/article/rs-49934/v1